Prostate Cancer, Hereditary, 1; Hpc1

Description

Familial prostate cancer (FPC) is a malignant tumor of the prostate with an early onset. FPC is either asymptomatic or causes mictionary symptoms, erectile dysfunction, bone pain, venous compression and infectious or inflammatory syndrome (for the metastatic forms). It is also characterized by familial antecedents.

Clinical Features

Phenotypes and symptoms related to Prostate Cancer, Hereditary, 1; Hpc1

  • Neoplasm
  • Prostate cancer

Incidence and onset information

Not enough data available about incidence and published cases.


Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Prostate Cancer, Hereditary, 1; Hpc1 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
46,XY Disorders of Sex Development/Complete Gonadal Dysgenesis Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

AMHR2, AMH, MAMLD1, MAP3K1, ZFPM2, DHH, DYNC2H1, AKR1C2, B3GLCT, GATA4, SRD5A2, HSD17B3, NR5A1, SOX9, OPHN1, ATRX, LHCGR, SRY, DHCR7, ARX , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
9 %
46,XY Disorders of Sex Development/Complete Gonadal Dysgenesis Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

AMHR2, AMH, MAMLD1, MAP3K1, ZFPM2, DHH, DYNC2H1, AKR1C2, B3GLCT, GATA4, SRD5A2, HSD17B3, NR5A1, SOX9, OPHN1, ATRX, LHCGR, SRY, DHCR7, ARX , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
9 %
Prenatal SRD5A2 Gene Sequencing.

By GeneDx in United States.

SRD5A2
Specificity
100 %
Genes
9 %
Male Infertility Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

GALNTL5, ZMYND15, SUN5, TEX11, SLC26A8, SEPT12, NPAS2, TAF4B, PLCZ1, KLHL10, INSL3, CFAP43, CFAP44, BRDT, CBX2, AKR1C4, DMRT2, DMRT1, SYCE1, CCDC141 , (...)

View the complete list with 86 more genes
Specificity
1 %
Genes
9 %
Disorders of Sex Development (DSD) and Infertility Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

CHD4, TOE1, ATF3, BNC2, HHAT, GALNTL5, ZMYND15, SUN5, TEX11, SLC26A8, SEPT12, NPAS2, TAF4B, PLCZ1, KLHL10, INSL3, CFAP43, CFAP44, BRDT, CBX2 , (...)

View the complete list with 186 more genes
Specificity
1 %
Genes
17 %
Disorders of Sex Development (DSD) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

CHD4, TOE1, ATF3, BNC2, HHAT, INSL3, CBX2, AKR1C4, DMRT2, DMRT1, HOXA4, HOXB6, BMP7, MCM9, HS6ST1, NR3C1, TWIST2, TRAIP, KISS1, PTDSS1 , (...)

View the complete list with 138 more genes
Specificity
2 %
Genes
17 %
qGenEx Sex development disorders.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

CBX2, DMRT1, NR3C1, AMHR2, AMH, MAMLD1, WDR60, NEK1, FRAS1, RSPO1, MAP3K1, ZFPM2, TSPYL1, WNT4, ROR2, DHH, HOXA13, FREM2, GRIP1, DYNC2H1 , (...)

View the complete list with 28 more genes
Specificity
3 %
Genes
9 %
Invitae Disorders of Male Sex Development Panel.

By Invitae in United States.

MAP3K1, DHH, SRD5A2, NR5A1, NR0B1, SRY, AR, WT1
Specificity
13 %
Genes
9 %
Male pseudohermaphroditism due to 5-alpha-reductase deficiency type 2: SRD5A2 gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

SRD5A2
Specificity
100 %
Genes
9 %
SRD5A2.

By Fulgent Genetics Fulgent Genetics in United States.

SRD5A2
Specificity
100 %
Genes
9 %
46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency.

By Bioarray in Spain.

SRD5A2
Specificity
100 %
Genes
9 %
CarrierMap.

By Recombine in United States.

VPS53, SLC26A3, BCHE, HGD, GDF5, XPC, SLC7A9, LIFR, XPA, WRN, SEPSECS, MED17, ASNS, AMHR2, AMH, CYP19A1, HJV, HOGA1, TFR2, TTC37 , (...)

View the complete list with 281 more genes
Specificity
1 %
Genes
17 %
5-ALPHA REDUCTASE DEFICIENCY (MALE PSEUDOHERMAFRODISTISM).

By Laboratorio de Genetica Clinica SL in Spain.

SRD5A2, HSD17B3
Specificity
50 %
Genes
9 %
Nonsyndromic disorders of sexual development: gene sequencing panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

CBX2, AKR1C2, SRD5A2, HSD17B3, POR, ANOS1, LHCGR, AR, CYP17A1, CYP11A1, HSD3B2, STAR
Specificity
9 %
Genes
9 %
Steroid 5-Alpha-Reductase Deficiency.

By Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital in United States.

SRD5A2
Specificity
100 %
Genes
9 %
Abnormal/Ambiguous Genitalia Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

WDR60, SPECC1L, NEK1, FEZF1, ICK, IRF6, FRAS1, RSPO1, NSMF, MAP3K1, ZFPM2, CCNQ, TSPYL1, WNT7A, WNT4, TBX15, SEMA3A, ROR2, DNMT3B, DHH , (...)

View the complete list with 52 more genes
Specificity
2 %
Genes
9 %
Hypospadias Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

PTDSS1, PDE4D, CUL7, MAMLD1, SPECC1L, IRF6, FRAS1, MAP3K1, WNT7A, DNMT3B, HOXA13, FREM2, ESCO2, GRIP1, UBR1, EPG5, B3GLCT, BMP4, RBBP8, EVC2 , (...)

View the complete list with 41 more genes
Specificity
4 %
Genes
17 %
SRD5A2 Gene Sequencing.

By GeneDx in United States.

SRD5A2
Specificity
100 %
Genes
9 %
SRD5A2. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

SRD5A2
Specificity
100 %
Genes
9 %
5-alpha-reductase deficiency type 3 (sequence analysis of SRD5A2 gene).

By CGC Genetics in Portugal.

SRD5A2
Specificity
100 %
Genes
9 %
Female Infertility Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

CBX2, AKR1C4, STAG3, PRLR, PADI6, SOHLH1, DMRT2, DMRT1, SYCE1, CCDC141, AXL, MCM9, ZP1, NUP107, HS6ST1, SPRY4, DUSP6, FLRT3, NR3C1, KISS1 , (...)

View the complete list with 83 more genes
Specificity
1 %
Genes
9 %
Steroid 5-Alpha Reductase Deficiency.

By Molecular Genetics Laboratory BC Children's and BC Women's Hospitals in Canada.

SRD5A2
Specificity
100 %
Genes
9 %
Prostate cancer.

By Centogene AG - the Rare Disease Company in Germany.

SRD5A2
Specificity
100 %
Genes
9 %
Invitae Androgen Insensitivity Panel.

By Invitae in United States.

SRD5A2, AR
Specificity
50 %
Genes
9 %
Abnormal Genitalia/ Disorders of Sex Development Panel.

By Blueprint Genetics in Finland.

MKRN3, AMHR2, AMH, MAMLD1, IRF6, FRAS1, RSPO1, MAP3K1, ZFPM2, DHH, IL17RD, DYNC2H1, CYP19A1, CEP41, GATA4, SRD5A2, HSD17B3, NR5A1, SOX9, POR , (...)

View the complete list with 29 more genes
Specificity
3 %
Genes
9 %
Pseudovaginal Perineoscrotal Hypospadias, Sequencing SRD5A2 Gene.

By Reference Laboratory Genetics in Spain.

SRD5A2
Specificity
100 %
Genes
9 %
Pseudovaginal Perineoscrotal Hypospadias, Sequencing SRD5A2 Gene , Deletions-Duplications (MLPA) SRD5A2 Gene.

By Reference Laboratory Genetics in Spain.

SRD5A2
Specificity
100 %
Genes
9 %
MitoMet®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories in United States.

GSN, NEFH, SOD1, TEAD1, PHB, PLA2G2A, AKAP10, PNKD, PAX2, CPOX, ABCB7, TAZ, TIMM8A, GK, PDHA1, HCCS, NYX, FRMD7, OTC, RP2 , (...)

View the complete list with 617 more genes
Specificity
1 %
Genes
34 %
Monogenic Diabetes (MODY) Five Gene Evaluation (GCK,HNF1A,HNF1B,HNF4A,IPF1).

By Athena Diagnostics Inc in United States.

HNF4A, PDX1, GCK, HNF1B, HNF1A
Specificity
20 %
Genes
9 %
TCF2 (MODY5) DNA Sequencing and Deletion Test.

By Athena Diagnostics Inc in United States.

HNF1B
Specificity
100 %
Genes
9 %
Monogenic Diabetes (MODY) Four Gene Evaluation (GCK,HNF1A, HNF1B, HNF4A).

By Athena Diagnostics Inc in United States.

HNF4A, GCK, HNF1B, HNF1A
Specificity
25 %
Genes
9 %
Monogenic Diabetes (MODY) Three Gene Evaluation (GCK,HNF1A, HNF1B).

By Athena Diagnostics Inc in United States.

GCK, HNF1B, HNF1A
Specificity
34 %
Genes
9 %
Maturity-Onset Diabetes of the Young.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

EIF2AK3, GATA6, PTF1A, NEUROG3, GLIS3, BLK, KLF11, PAX4, RFX6, AKT2, SLC2A2, IER3IP1, CP, FOXP3, HNF4A, PDX1, INS, KCNJ11, ABCC8, CISD2 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
9 %
Maturity-onset Diabetes of the Young Panel.

By Genetic Diagnostic Laboratory University of Pennsylvania School of Medicine in United States.

INSR, BLK, KLF11, PAX4, AKT2, HNF4A, PDX1, INS, KCNJ11, CEL, ABCC8, GCK, HNF1B, NEUROD1, HNF1A
Specificity
7 %
Genes
9 %
MODY Panel.

By Genetic Services Laboratory University of Chicago in United States.

APPL1, BLK, KLF11, PAX4, HNF4A, PDX1, INS, KCNJ11, CEL, ABCC8, GCK, HNF1B, NEUROD1, HNF1A
Specificity
8 %
Genes
9 %
MODY5 - Maturity onset diabetes of the young type 5.

By Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital in New Zealand.

HNF1B
Specificity
100 %
Genes
9 %
Maturity onset diabetes of the young (MODY) Panel.

By Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital in New Zealand.

HNF4A, GCK, HNF1B, HNF1A
Specificity
25 %
Genes
9 %
Polycystic kidney and liver disease modifier panel.

By Sheffield Diagnostic Genetics Service Sheffield Children's NHS Foundation Trust in United Kingdom.

GANAB, SEC61A1, DZIP1L, DNAJB11, SEC61B, SEC63, REN, PRKCSH, PKD1, PKD2, UMOD, PKHD1, TSC1, TSC2, ALG8, HNF1B, LRP5
Specificity
6 %
Genes
9 %
MODY Panel.

By Ambry Genetics in United States.

HNF4A, PDX1, GCK, HNF1B, HNF1A
Specificity
20 %
Genes
9 %
HNF4,GCK,HNF1A,HNF1B, NextGeneDx.Complete sequencing by NGS.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

HNF4A, GCK, HNF1B, HNF1A
Specificity
25 %
Genes
9 %
MODY (deletion/duplication analysis of GCK, HNF1A, HNF1B and HNF4A genes).

By CGC Genetics in Portugal.

HNF4A, GCK, HNF1B, HNF1A
Specificity
25 %
Genes
9 %
MODY (NGS panel for 13 genes).

By CGC Genetics in Portugal.

BLK, KLF11, PAX4, HNF4A, PDX1, INS, KCNJ11, CEL, ABCC8, GCK, HNF1B, NEUROD1, HNF1A
Specificity
8 %
Genes
9 %
Renal cysts and diabetes syndrome (sequence analysis of HNF1B genes).

By CGC Genetics in Portugal.

HNF1B
Specificity
100 %
Genes
9 %
Renal cell carcinoma (sequence analysis of HNF1B genes).

By CGC Genetics in Portugal.

HNF1B
Specificity
100 %
Genes
9 %
Renal cysts and diabetes syndrome (sequence analysis of HNF1B genes).

By CGC Genetics in Portugal.

HNF1B
Specificity
100 %
Genes
9 %
Renal cysts and diabetes syndrome (deletions/duplications analysis of HNF1B genes).

By CGC Genetics in Portugal.

HNF1B
Specificity
100 %
Genes
9 %
Familial hypoplastic, glomerulocystic kidney.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany.

HNF1B
Specificity
100 %
Genes
9 %
Renal cysts and diabetes syndrome.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany.

HNF1B
Specificity
100 %
Genes
9 %
Renal Cysts and Diabetes Syndrome.

By Exeter Molecular Genetics Laboratory in United Kingdom.

HNF1B
Specificity
100 %
Genes
9 %
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

GANAB, DNAJB11, PKD1, PKD2, HNF1B
Specificity
20 %
Genes
9 %
Autosomal Dominant and Recessive Polycystic Kidney Disease (ADPKD and ARPKD) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

GANAB, DZIP1L, DNAJB11, PKD1, PKD2, PKHD1, HNF1B
Specificity
15 %
Genes
9 %
Congenital Abnormalities of the Kidney and Urinary Tract (CAKUT) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DSTYK, CHD1L, HOXA4, HOXB6, CDC5L, GREB1L, BMP7, SIX2, TRAP1, UPK3A, AGTR1, TBX18, FGF20, ITGA8, PBX1, ROBO2, AGT, SOX17, HPSE2, LIFR , (...)

View the complete list with 29 more genes
Specificity
3 %
Genes
9 %
Hypomagnesemia Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

EGF, CNNM2, TRPM6, FXYD2, CLDN19, CLDN16, FAM111A, EGFR, PCBD1, KCNJ10, KCNA1, BSND, SLC12A3, CASR, SARS2, HNF1B
Specificity
7 %
Genes
9 %
Hereditary Cystic Kidney Diseases Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

MAPKBP1, GANAB, SEC61A1, DZIP1L, DNAJB11, DICER1, MUC1, CRB2, ANKS6, CEP83, ZNF423, CEP164, IFT172, NOTCH2, GLIS2, NEK8, RPGRIP1L, TTC21B, SDCCAG8, WDR19 , (...)

View the complete list with 21 more genes
Specificity
3 %
Genes
9 %
Polycystic kidney disease and related disorders NGS panel.

By Connective Tissue Gene Tests in United States.

BICC1, GANAB, SEC61A1, MUC1, ANKS6, ZNF423, NOTCH2, ATP6V0A4, GLIS3, TMEM231, OFD1, PKD1, PKD2, UMOD, PKHD1, TSC1, TSC2, ALG9, NPHP3, HNF1B , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
9 %
Polycystic kidney disease and related disorders Deletion / Duplication panel.

By Connective Tissue Gene Tests in United States.

BICC1, GANAB, SEC61A1, MUC1, ANKS6, ZNF423, NOTCH2, ATP6V0A4, GLIS3, TMEM231, OFD1, PKD1, PKD2, UMOD, PKHD1, TSC1, TSC2, ALG9, NPHP3, HNF1B , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
9 %
Polycystic kidney disease and related disorders Comprehensive panel.

By Connective Tissue Gene Tests in United States.

BICC1, GANAB, SEC61A1, MUC1, ANKS6, ZNF423, NOTCH2, ATP6V0A4, GLIS3, TMEM231, OFD1, PKD1, PKD2, UMOD, PKHD1, TSC1, TSC2, ALG9, NPHP3, HNF1B , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
9 %
Renal cell carcinoma.

By Institute of Human Genetics Cologne University in Germany.

WT1-AS, DIS3L2, DICER1, CDKN1B, MAX, MET, FLCN, TSC1, TSC2, HNF1B, VHL
Specificity
10 %
Genes
9 %
Hereditary kidney disorders - different panels.

By Institute of Human Genetics Cologne University in Germany.

CLDN10, TMEM260, KANK3, SLC6A20, MAGEC1, TBC1D1, SLC41A1, SLC36A2, SLC22A10, KCNMB1, NRIP1, MAGED2, DYNC2LI1, IFT52, RMND1, MAPKBP1, MOCOS, SLC26A1, PDE3A, FN1 , (...)

View the complete list with 391 more genes
Specificity
1 %
Genes
9 %
Nephrology Endocrinology and Electrolytes - panels.

By MGZ Medical Genetics Center in Germany.

UPK2, DACH1, DSTYK, CHD1L, CDC5L, BMP7, SIX2, TRAP1, UPK3A, AGTR1, ANLN, FGF20, ITGA8, PTPRO, EMP2, CHRM3, BICC1, ROBO2, ARHGDIA, AGT , (...)

View the complete list with 97 more genes
Specificity
1 %
Genes
9 %
Hepatic and pancreatic diseases - panels.

By MGZ Medical Genetics Center in Germany.

UTP4, SLC27A5, ALAD, MYO5B, NR1H4, HMBS, UROD, PEX11B, SLCO1B3, SLCO1B1, HSD3B7, NOTCH2, EPHX1, CLDN1, ABCC2, BAAT, VIPAS39, VPS33B, AKR1D1, UROS , (...)

View the complete list with 49 more genes
Specificity
2 %
Genes
9 %
CentoICU platinum plus.

By Centogene AG - the Rare Disease Company in Germany.

OPLAH, PPM1K, IKBKB, LCK, CABS1, SOX6, OPRM1, IL2, CTPS1, IRF8, CD247, ADK, UQCC2, MPC1, UPB1, CORO1A, CD3G, MCM4, UQCRC2, GPHN , (...)

View the complete list with 494 more genes
Specificity
1 %
Genes
17 %
CentoICU platinum.

By Centogene AG - the Rare Disease Company in Germany.

FRAS1, TSPYL1, IL2RA, CARD11, NOTCH2, TNFRSF13C, PRKDC, ICOS, CD81, CR2, CD19, F7, JAGN1, ABCC2, NFKB2, IL12RB1, COL7A1, COL17A1, ITGA6, ITGB4 , (...)

View the complete list with 494 more genes
Specificity
1 %
Genes
17 %
Renal Cysts and Diabetes Syndrome.

By Medical Genetics Laboratory Diagenom GmbH in Germany.

HNF1B
Specificity
100 %
Genes
9 %
Renal cysts and diabetes syndrome.

By bio.logis Center for Human Genetics Diagnosticum in Germany.

HNF1B
Specificity
100 %
Genes
9 %
Renal cell carcinoma Panel.

By CeGaT GmbH in Germany.

BAP1, MITF, MET, FLCN, SDHD, PALB2, TSC1, TSC2, SDHA, SDHB, FH, SDHC, HNF1B, SDHAF2, WT1, HNF1A, TP53, PTEN, MLH1, MSH6 , (...)

View the complete list with 4 more genes
Specificity
5 %
Genes
9 %
Maturity-Onset Diabetes of the Young Type 5 (HNF1B, MODY5, RCAD).

By MVZ Dortmund Dr. Eberhard & Partner in Germany.

HNF1B
Specificity
100 %
Genes
9 %
Maturity Onset Diabetes of the Young (MODY).

By Asper Biogene Asper Biogene LLC in Estonia.

ZFP57, BLK, KLF11, PAX4, RFX6, HNF4A, PDX1, INS, KCNJ11, CEL, ABCC8, GCK, HNF1B, NEUROD1, HNF1A
Specificity
7 %
Genes
9 %
Cardiovascular Diseases_General Panel.

By Health in Code in Spain.

CH25H, BMP10, TRIB1, TOPBP1, ISL1, GREM2, HAND2, SLC25A40, NNT, PPARA, MYOM1, LPA, SLC22A8, IRX3, KCNK17, PPP1R13L, PERP, FHOD3, FOXD4, SMAD1 , (...)

View the complete list with 360 more genes
Specificity
1 %
Genes
17 %
MODY 05.

By Praxis fuer Humangenetik Wien in Austria.

HNF1B
Specificity
100 %
Genes
9 %
qChip.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

SEM1, IGF2, CBFB, TRAPPC10, FBXW11, TBX3, HDAC4, TRPS1, STS, HOXD13, LMNB1, MID2, IRF6, MNX1, SIM1, DISP1, MYCN, GATA4, ZIC3, VEGFA , (...)

View the complete list with 106 more genes
Specificity
1 %
Genes
9 %
Diabetes mellitus, noninsulin-dependent.

By MedGene in Slovakia.

HNF1B
Specificity
100 %
Genes
9 %
Endocrine Disorders: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

GDF9, KISS1, TAC3, FSHR, BMP15, NOBOX, FIGLA, PSMC3IP, NSMF, CYP19A1, AGPAT2, CIDEC, TBC1D4, INSR, EIF2AK3, GATA6, PTF1A, GLIS3, BLK, KLF11 , (...)

View the complete list with 37 more genes
Specificity
2 %
Genes
9 %
KidneySeq - 264 Genes.

By Iowa Institute of Human Genetics University of Iowa in United States.

FN1, FAN1, DSTYK, CHD1L, SIX2, ARHGAP24, NUP107, NUP93, NUP205, FAT1, XPO5, SGPL1, TRAP1, UPK3A, AGTR1, TBX18, EHHADH, ANLN, FGF20, KCTD1 , (...)

View the complete list with 232 more genes
Specificity
1 %
Genes
9 %
Cystic Kidney Disease Panel.

By Blueprint Genetics in Finland.

MAPKBP1, GANAB, SEC61A1, DZIP1L, CRB2, ANKS6, CEP83, ZNF423, CEP164, IFT172, NOTCH2, GLIS2, NEK8, RPGRIP1L, TTC21B, SDCCAG8, WDR19, SIX5, DCDC2, OFD1 , (...)

View the complete list with 20 more genes
Specificity
3 %
Genes
9 %
Hypomagnesemia Panel.

By Blueprint Genetics in Finland.

NIPA2, EGF, CNNM2, TRPM6, FXYD2, CLDN19, CLDN16, FAM111A, PCBD1, CNNM4, MAGT1, KCNJ10, KCNA1, CLCNKB, BSND, SLC12A3, CASR, SARS2, HNF1B
Specificity
6 %
Genes
9 %
MODY Panel.

By Blueprint Genetics in Finland.

BLK, KLF11, PAX4, RFX6, HNF4A, PDX1, INS, KCNJ11, ABCC8, GCK, HNF1B, NEUROD1, HNF1A
Specificity
8 %
Genes
9 %
Comprehensive Metabolism Panel.

By Blueprint Genetics in Finland.

PRKAG3, NIPA2, GLUL, SLC6A9, SLC25A26, ADK, GMPPA, TANGO2, COQ5, COQ7, MOCOS, FLAD1, CTH, DPYS, UPB1, ALAD, ABCD3, STT3A, STT3B, NGLY1 , (...)

View the complete list with 414 more genes
Specificity
1 %
Genes
9 %
HNF1B Gene Sequencing and Deletion/Duplication Analysis.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

HNF1B
Specificity
100 %
Genes
9 %
Monogenic Diabetes NGS and Deletion/Duplication Panel.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

G6PC2, INSR, EIF2AK3, NEUROG3, GLIS3, BLK, KLF11, PAX4, SLC2A2, HADH, FOXP3, HNF4A, PDX1, INS, KCNJ11, CEL, ABCC8, GLUD1, UCP2, GCK , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
9 %
Rapid microarray (CGH and SNP).

By Allele Diagnostics Allele Diagnostics in United States.

CRK, SEM1, IGF2, FBXW4, YWHAE, TBX3, HDAC4, TRPS1, STS, GRIK2, FLI1, PREPL, MAMLD1, ARSE, IRF6, CCNQ, MNX1, NFIA, EDA, XK , (...)

View the complete list with 153 more genes
Specificity
1 %
Genes
9 %
High-Resolution Rapid Microarray (CGH and SNP).

By Allele Diagnostics Allele Diagnostics in United States.

CRK, SEM1, IGF2, FBXW4, YWHAE, TBX3, HDAC4, TRPS1, STS, GRIK2, FLI1, PREPL, MAMLD1, ARSE, IRF6, CCNQ, MNX1, NFIA, EDA, XK , (...)

View the complete list with 153 more genes
Specificity
1 %
Genes
9 %
Next Generation Sequencing for Jaundice Associated Genes Variation Test.

By National Taiwan University Hospital A1 Center National Taiwan University Hospital in Taiwan.

FGF19, ONECUT1, HES1, ABCC4, ABCC3, SLCO2B1, SLCO1A2, SLC51B, SLC51A, CHMP5, FOXM1, CD14, MYO5B, NR1H4, COPA, CYP7A1, SEC63, SLCO1B3, SLCO1B1, HSD3B7 , (...)

View the complete list with 53 more genes
Specificity
2 %
Genes
9 %
DIABETES MODY & NEONATAL DIABETES : NGS PANEL.

By Laboratorio de Genetica Clinica SL in Spain.

ZFP57, INSR, EIF2AK3, PTF1A, GLIS3, BLK, KLF11, PAX4, RFX6, SLC2A2, IER3IP1, FOXP3, HNF4A, PDX1, INS, KCNJ11, ABCC8, GLUD1, GCK, HNF1B , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
9 %
Maturity-onset diabetes of the young type 5.

By LifeLabs Genetics in Canada.

HNF1B
Specificity
100 %
Genes
9 %
MODY panel.

By LifeLabs Genetics in Canada.

ZFP57, NKX2-2, BLK, KLF11, PAX4, RFX6, HNF4A, PDX1, INS, CEL, ABCC8, GCK, HNF1B, NEUROD1, HNF1A
Specificity
7 %
Genes
9 %
Diabetes MODY Type 5, Sequencing HNF1B Gene.

By Reference Laboratory Genetics in Spain.

HNF1B
Specificity
100 %
Genes
9 %
Diabetes MODY Type 5, Deletion-Duplication (MLPA) HNF1B Gene.

By Reference Laboratory Genetics in Spain.

HNF1B
Specificity
100 %
Genes
9 %
Permanent Neonatal Diabetes Mellitus , Panel Massive Sequencing (NGS) 16 Genes.

By Reference Laboratory Genetics in Spain.

EIF2AK3, GATA6, PTF1A, NEUROG3, GLIS3, RFX6, FOXP3, SLC19A2, PDX1, INS, KCNJ11, ABCC8, GCK, WFS1, HNF1B, NEUROD1
Specificity
7 %
Genes
9 %
Hereditary Renal Cancer , Panel Massive Sequencing (NGS) 21 Genes.

By Reference Laboratory Genetics in Spain.

DIS3L2, BAP1, MITF, MET, FLCN, SDHD, TSC1, TSC2, SDHB, FH, HNF1B, WT1, HNF1A, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
9 %
Polycystic Kidney Disease.

By Genome.One in Australia.

GANAB, OFD1, PKD1, PKD2, UMOD, PKHD1, TSC1, TSC2, HNF1B
Specificity
12 %
Genes
9 %
Tempus xT assay.

By Tempus Labs, Inc. in United States.

HLA-DRB5, HLA-C, PPP6C, ZNRF3, FOXQ1, TBC1D12, WEE1, YEATS4, POU2F2, C8orf34, SEMA3C, PDPK1, HLA-G, LAG3, CCDC6, MEF2B, AURKA, TOP1, P2RY8, FGF4 , (...)

View the complete list with 571 more genes
Specificity
2 %
Genes
59 %
Tempus xO assay.

By Tempus Labs, Inc. in United States.

SETD6, PIM3, MAP3K10, PDGFA, MAP3K11, PAK2, KHSRP, WASL, CASC11, GLIS1, NRG2, SOX21, SMARCC1, CUL4A, UTY, WNT9A, TEF, CHIC1, TRIM28, CDK11B , (...)

View the complete list with 1693 more genes
Specificity
1 %
Genes
59 %
HNF1B DNA Sequencing and Deletion Evaluation.

By Athena Diagnostics Inc in United States.

HNF1B
Specificity
100 %
Genes
9 %
TCF2 (MODY5) DNA Sequencing Test.

By Athena Diagnostics Inc in United States.

HNF1B
Specificity
100 %
Genes
9 %
HNF1B Sequencing.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

HNF1B
Specificity
100 %
Genes
9 %
HNF1B Deletion/duplication analysis.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

HNF1B
Specificity
100 %
Genes
9 %
MODY Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

APPL1, BLK, KLF11, PAX4, HNF4A, PDX1, INS, KCNJ11, CEL, ABCC8, GCK, HNF1B, NEUROD1, HNF1A
Specificity
8 %
Genes
9 %
Renal Cystic Disorders Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

REN, MUC1, CRB2, BMPER, ANKS6, CEP83, CEP164, CSPP1, PDE6D, KIF14, TMEM107, CEP104, KIAA0556, IFT172, TCTN3, NOTCH2, GLIS3, B9D2, ARL13B, GLIS2 , (...)

View the complete list with 55 more genes
Specificity
2 %
Genes
9 %
Renal Cysts and Diabetes Syndrome.

By Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital in New Zealand.

HNF1B
Specificity
100 %
Genes
9 %
ExomePLUS Cystic Disease & Dysplasia/Agenesis.

By Laboratory for Molecular Medicine Laboratory for Molecular Medicine (Partners HealthCare Personalized Medicine) in United States.

REN, MUC1, FRAS1, ANKS6, BMP4, ACE, GATA3, PKD2, UMOD, PKHD1, TSC1, TSC2, PAX2, IQCB1, NPHP4, CEP290, NPHP1, NPHP3, HNF1B, WT1 , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
9 %
HNF1B. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

HNF1B
Specificity
100 %
Genes
9 %
MODY 5 (sequence analysis of HNF1B gene).

By CGC Genetics in Portugal.

HNF1B
Specificity
100 %
Genes
9 %
Diabetes mellitus permanent neonatal (NGS panel for 13 genes).

By CGC Genetics in Portugal.

GATA6, PTF1A, GLIS3, RFX6, IER3IP1, SLC19A2, PDX1, INS, KCNJ11, ABCC8, GCK, HNF1B, PAX6
Specificity
8 %
Genes
9 %
Renal cysts and diabetes syndrome (deletions/duplications analysis of HNF1B genes).

By CGC Genetics in Portugal.

HNF1B
Specificity
100 %
Genes
9 %
Hypomagnesemia (NGS panel for 17 genes).

By CGC Genetics in Portugal.

EGF, CNNM2, TRPM6, FXYD2, CLDN19, CLDN16, FAM111A, EGFR, PCBD1, KCNJ10, KCNA1, CLCNKB, BSND, SLC12A3, CASR, SARS2, HNF1B
Specificity
6 %
Genes
9 %
Renal cell carcinoma (sequence analysis of HNF1B genes).

By CGC Genetics in Portugal.

HNF1B
Specificity
100 %
Genes
9 %
Hypomagnesemia (NGS panel for 17 genes).

By CGC Genetics in Portugal.

EGF, CNNM2, TRPM6, FXYD2, CLDN19, CLDN16, FAM111A, EGFR, PCBD1, KCNJ10, KCNA1, CLCNKB, BSND, SLC12A3, CASR, SARS2, HNF1B
Specificity
6 %
Genes
9 %
Maturity Onset Diabetes of the Young (Types 1 to 10).

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany.

BLK, KLF11, PAX4, HNF4A, PDX1, INS, CEL, GCK, HNF1B, NEUROD1, HNF1A
Specificity
10 %
Genes
9 %
Renal Cysts and Diabetes Syndrome via HNF1B Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

HNF1B
Specificity
100 %
Genes
9 %
Maturity Onset Diabetes of the Young (MODY) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

APPL1, BLK, KLF11, PAX4, HNF4A, PDX1, INS, KCNJ11, ABCC8, GCK, HNF1B, NEUROD1, HNF1A
Specificity
8 %
Genes
9 %
HNF1B.

By Department of Clinical Genetics Odense University Hospital in Denmark.

HNF1B
Specificity
100 %
Genes
9 %
Renal cysts and diabetes syndrome.

By Institute of Human Genetics Cologne University in Germany.

HNF1B
Specificity
100 %
Genes
9 %
Maturity Onset Diabetes of the Young.

By Synlab MVZ Humane Genetik München Synlab MVZ Humane Genetik München in Germany.

KLF11, HNF4A, PDX1, GCK, HNF1B, NEUROD1, HNF1A
Specificity
15 %
Genes
9 %
HNF1B.

By Genome Diagnostics Laboratory University Medical Center Utrecht in Netherlands.

HNF1B
Specificity
100 %
Genes
9 %
MODY panel.

By Centogene AG - the Rare Disease Company in Germany.

ZFP57, NKX2-2, BLK, KLF11, PAX4, RFX6, HNF4A, PDX1, INS, CEL, ABCC8, GCK, HNF1B, NEUROD1, HNF1A
Specificity
7 %
Genes
9 %
Maturity-onset diabetes of the young type 5.

By Centogene AG - the Rare Disease Company in Germany.

HNF1B
Specificity
100 %
Genes
9 %
Maturity onset diabetes mellitus in young.

By bio.logis Center for Human Genetics Diagnosticum in Germany.

BLK, KLF11, PAX4, HNF4A, PDX1, INS, CEL, GCK, HNF1B, NEUROD1, HNF1A
Specificity
10 %
Genes
9 %
Renal Dysplasia, Renal Agenesia, CAKUT Panel.

By CeGaT GmbH in Germany.

ALDH1A2, OSR1, DSTYK, CHD1L, SPRY1, TRAP1, UPK3A, TBX18, FGF20, ITGA8, BICC1, ROBO2, SOX17, GDNF, FRAS1, FREM2, GRIP1, BMP4, FREM1, SDCCAG8 , (...)

View the complete list with 12 more genes
Specificity
4 %
Genes
9 %
Cystic Kidney Disease Panel.

By CeGaT GmbH in Germany.

BICC1, MUC1, SIX5, PKD2, UMOD, PKHD1, PAX2, HNF1B, EYA1
Specificity
12 %
Genes
9 %
Renal Cysts and Diabetes Syndrome (HNF1B, RCAD).

By MVZ Dortmund Dr. Eberhard & Partner in Germany.

HNF1B
Specificity
100 %
Genes
9 %
Maturity-onset diabetes of the young MODY.

By Health in Code in Spain.

TBC1D4, EIF2AK3, GATA6, PTF1A, NEUROG3, GLIS3, BLK, KLF11, PAX4, RFX6, SLC2A2, IER3IP1, FOXP3, HNF4A, PDX1, INS, KCNJ11, CEL, GCK, WFS1 , (...)

View the complete list with 3 more genes
Specificity
5 %
Genes
9 %
Dyslipidemias / Early atherosclerosis.

By Health in Code in Spain.

CH25H, TRIB1, SLC25A40, PPARA, LPA, SLC22A8, CYP3A5, LRP6, INSIG2, CYP3A4, SAR1B, MYLIP, SLCO1B1, PLTP, LIPC, APOC3, AGPAT2, PLIN1, CIDEC, TBC1D4 , (...)

View the complete list with 64 more genes
Specificity
2 %
Genes
9 %
Diabetes mellitus, noninsulin-dependent.

By Praxis fuer Humangenetik Wien in Austria.

HNF1B
Specificity
100 %
Genes
9 %
MODY 05.

By MedGene in Slovakia.

HNF1B
Specificity
100 %
Genes
9 %
MODY type 5: HNF1B gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

HNF1B
Specificity
100 %
Genes
9 %
DIABETES (MODY).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BLK, KLF11, PAX4, SLC2A2, HNF4A, PDX1, KCNJ11, GCK, HNF1B, NEUROD1, HNF1A
Specificity
10 %
Genes
9 %
Diabetes mellitus, neonatal permanent.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

EIF2AK3, GATA6, PTF1A, NEUROG3, GLIS3, RFX6, FOXP3, SLC19A2, PDX1, INS, KCNJ11, ABCC8, GCK, WFS1, HNF1B, PAX6, NEUROD1
Specificity
6 %
Genes
9 %
Endocrine Disorders: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

GDF9, KISS1, TAC3, FSHR, BMP15, NOBOX, FIGLA, PSMC3IP, NSMF, CYP19A1, AGPAT2, CIDEC, TBC1D4, INSR, EIF2AK3, GATA6, PTF1A, GLIS3, BLK, KLF11 , (...)

View the complete list with 37 more genes
Specificity
2 %
Genes
9 %
Neonatal and Adult Cholestasis: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SLC27A5, NR1H4, CYP7A1, PEX11B, HSD3B7, NOTCH2, CLDN1, ABCC2, BAAT, VIPAS39, VPS33B, AKR1D1, ABCG8, ABCG5, PEX5, PEX12, PEX10, PEX26, PEX16, PEX3 , (...)

View the complete list with 37 more genes
Specificity
2 %
Genes
9 %
Diabetes-Obesity NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

NTRK2, SIM1, EIF2AK3, PTF1A, NEUROG3, GLIS3, RFX6, BDNF, GNAS, SDCCAG8, WDPCP, MAGEL2, FOXP3, HNF4A, PDX1, INS, MC4R, KCNJ11, CEL, ABCC8 , (...)

View the complete list with 24 more genes
Specificity
3 %
Genes
9 %
MODY Neonatal Diabetes NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

ZFP57, INSR, EIF2AK3, GATA6, PTF1A, NEUROG3, GLIS3, BLK, KLF11, PAX4, RFX6, AKT2, SLC2A2, HADH, IER3IP1, CP, FOXP3, HNF4A, PDX1, INS , (...)

View the complete list with 10 more genes
Specificity
4 %
Genes
9 %
HNF1B.

By Fulgent Genetics Fulgent Genetics in United States.

HNF1B
Specificity
100 %
Genes
9 %
Renal Malformation Panel.

By Blueprint Genetics in Finland.

DSTYK, PBX1, ROBO2, AGT, REN, CCNQ, FREM2, BMP4, FREM1, ACE, ACTG2, FANCB, FOXC2, GATA3, SIX1, SIX5, SALL1, PAX2, RET, HNF1B , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
9 %
Comprehensive Monogenic Diabetes Panel.

By Blueprint Genetics in Finland.

ZFP57, INSR, EIF2AK3, GATA6, PTF1A, NEUROG3, GLIS3, BLK, KLF11, PAX4, RFX6, SLC2A2, HADH, FOXP3, HNF4A, PDX1, INS, KCNJ11, ABCC8, GLUD1 , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
9 %
Renal cysts and diabetes syndrome.

By Bioarray in Spain.

HNF1B
Specificity
100 %
Genes
9 %
Cystic Disease and Nephronopthisis Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

BICC1, CRB2, GLIS2, NEK8, RPGRIP1L, TTC21B, SIX5, PKD1, PKD2, UMOD, AHI1, PKHD1, PAX2, IQCB1, XPNPEP3, NPHP4, CEP290, NPHP1, NPHP3, TMEM67 , (...)

View the complete list with 3 more genes
Specificity
5 %
Genes
9 %
Maturity-Onset Diabetes of the Young NGS and Deletion/Duplication Panel.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

BLK, KLF11, PAX4, HNF4A, PDX1, INS, KCNJ11, CEL, ABCC8, GCK, HNF1B, NEUROD1, HNF1A
Specificity
8 %
Genes
9 %
MATURITY-ONSET DIABETES OF THE YOUNG (MODY) TYPE 5.

By Laboratorio de Genetica Clinica SL in Spain.

HNF1B
Specificity
100 %
Genes
9 %
Diabetes MODY, Panel Massive Sequencing (NGS) 11 Genes.

By Reference Laboratory Genetics in Spain.

BLK, KLF11, PAX4, SLC2A2, HNF4A, PDX1, KCNJ11, GCK, HNF1B, NEUROD1, HNF1A
Specificity
10 %
Genes
9 %
Familial Hypomagnesemia , Panel Massive Sequencing (NGS) 14 Genes.

By Reference Laboratory Genetics in Spain.

EGF, CNNM2, TRPM6, FXYD2, CLDN19, CLDN16, PCBD1, KCNJ10, KCNA1, CLCNKB, SLC12A3, CASR, SARS2, HNF1B
Specificity
8 %
Genes
9 %
Renal Cysts and Diabetes Syndrome.

By Labor Dr. Wisplinghoff in Germany.

HNF1B
Specificity
100 %
Genes
9 %
Mitochondrial Oxidative Phosphorylation Deficiency Sequencing Panel (Nuclear Genes Only) with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

COA7, TRIT1, SFXN4, NSUN3, COQ5, TMEM126B, TRMT10C, RMND1, VARS2, TARS2, LYRM4, MRPL12, TRMT5, PARS2, MRPS7, MRPS23, MRPL44, COX7B, NDUFB11, COQ7 , (...)

View the complete list with 154 more genes
Specificity
1 %
Genes
9 %
Prostate Cancer Panel.

By CeGaT GmbH in Germany.

CD82, MXI1, MSR1, BTNL2, HOXB13, CHEK2, CDH1, AR, ZFHX3, RNASEL, ELAC2, BRCA2, BRCA1
Specificity
54 %
Genes
59 %
Nuclear encoded Mitochondriopathies Panel.

By CeGaT GmbH in Germany.

CYC1, NDUFB9, MPC1, ATP5F1A, YWHAE, UQCRC2, DECR1, CHCHD10, PET100, COA5, SERAC1, COX20, SLC25A1, IBA57, HOGA1, COQ8B, IDH1, HADH, EARS2, TPK1 , (...)

View the complete list with 263 more genes
Specificity
1 %
Genes
9 %
Arrhythmia General Panel.

By Health in Code in Spain.

GREM2, NNT, MYOM1, IRX3, KCNK17, PPP1R13L, PERP, FHOD3, FOXD4, NKX2-6, MRPL44, KCND2, COA6, TRIM63, KLF10, PKP4, TNNI3K, CALM3, CALR3, MIB1 , (...)

View the complete list with 198 more genes
Specificity
1 %
Genes
9 %
Nuclear-Mito NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

CNR1, CHDH, CLYBL, NIPSNAP3A, IDE, IMMT, LETM1, MAVS, RAB11FIP5, POLRMT, PTGES2, PPARGC1A, AS3MT, ACSM3, ACSL5, DMAC2, ATP10D, NDUFB1, HK2, ECI1 , (...)

View the complete list with 484 more genes
Specificity
1 %
Genes
17 %
ELAC2.

By Fulgent Genetics Fulgent Genetics in United States.

ELAC2
Specificity
100 %
Genes
9 %
Comprehensive Cardiology Panel.

By Blueprint Genetics in Finland.

PLEKHM2, PPA2, LRRC10, FBXO32, MYBPHL, CDH2, HAND1, FOXD4, TECRL, RMND1, GTPBP3, MYL4, TNNI3K, TAB2, CALM3, CALR3, ALPK3, TBX20, GATA5, RBCK1 , (...)

View the complete list with 165 more genes
Specificity
1 %
Genes
9 %
Phosphorus Hypertrophic Cardiomyopathy Including Recessive Pediatric Syndromes Panel.

By Phosphorus Diagnostics LLC in United States.

VCL, MYL3, MYL2, CSRP3, ACTN2, TNNT2, TPM1, PLN, PRKAG2, TNNI3, TNNC1, ACTC1, LAMP2, CACNA1C, TCAP, MYBPC3, FHL1, BAG3, LDB3, FLNC , (...)

View the complete list with 11 more genes
Specificity
4 %
Genes
9 %
Combined oxidative phosphorylation deficiency 17 (sequence analysis of ELAC2 gene).

By CGC Genetics in Portugal.

ELAC2
Specificity
100 %
Genes
9 %
Prostate cancer.

By Centogene AG - the Rare Disease Company in Germany.

ELAC2
Specificity
100 %
Genes
9 %
Hypertrophic cardiomyopathy extended panel.

By Health in Code in Spain.

MYOM1, FHOD3, MRPL44, COA6, TRIM63, KLF10, CALR3, CAVIN4, COA5, OBSL1, AGPAT2, OBSCN, FHL2, VCL, MYL3, MYL2, CSRP3, ACTN2, MYOZ2, JPH2 , (...)

View the complete list with 84 more genes
Specificity
1 %
Genes
9 %
Cardiomyopathies General Panel.

By Health in Code in Spain.

NNT, MYOM1, PPP1R13L, PERP, FHOD3, FOXD4, MRPL44, COA6, TRIM63, KLF10, PKP4, TNNI3K, CALR3, MIB1, TBX20, CAVIN4, CHRM2, GATA5, CTNNA3, COA5 , (...)

View the complete list with 153 more genes
Specificity
1 %
Genes
9 %
Cardiomyopathy Panel.

By Blueprint Genetics in Finland.

PLEKHM2, PPA2, LRRC10, FBXO32, MYBPHL, CDH2, HAND1, FOXD4, RMND1, GTPBP3, MYL4, TNNI3K, TAB2, CALR3, ALPK3, TBX20, RBCK1, CTNNA3, EPG5, XK , (...)

View the complete list with 135 more genes
Specificity
1 %
Genes
9 %
Hypertrophic Cardiomyopathy (HCM) Panel.

By Blueprint Genetics in Finland.

ALPK3, EPG5, APOA1, MYL3, MYL2, CSRP3, ACTN2, JPH2, TNNT2, TPM1, PRKAG2, TNNI3, ACTC1, ABCC9, LAMP2, ACTA1, MYBPC3, FHL1, BAG3, FLNC , (...)

View the complete list with 18 more genes
Specificity
3 %
Genes
9 %
Otogenetics Hereditary Cancers.

By Otogenetics in United States.

PALLD, RAD51, NF1, NTRK1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, MET, CDKN2A, CDK4, STK11, CDH1, PALB2, PTCH1, NBN , (...)

View the complete list with 19 more genes
Specificity
13 %
Genes
42 %
Familial Prostate Cancer , Panel Massive Sequencing (NGS) 11 Genes.

By Reference Laboratory Genetics in Spain.

MSR1, CHEK2, CDH1, NBN, AR, ZFHX3, RNASEL, ELAC2, EPCAM, BRCA2, BRCA1
Specificity
64 %
Genes
59 %
Phosphorus Pan Cardiomyopathy Including Recessive Pediatric Syndromes Panel.

By Phosphorus Diagnostics LLC in United States.

VCL, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, TNNT2, TPM1, JUP, DSG2, PLN, PRKAG2, TNNI3, TNNC1, TGFB3, ACTC1, RYR2, PKP2, ABCC9 , (...)

View the complete list with 40 more genes
Specificity
2 %
Genes
9 %
Phosphorus Pan Arrhythmia and Cardiomyopathy Including Rasopathies and Recessive Pediatric Syndromes Panel.

By Phosphorus Diagnostics LLC in United States.

CALM3, SCN10A, VCL, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, TNNT2, TPM1, JUP, DSG2, PLN, PRKAG2, TNNI3, TNNC1, TGFB3, ACTC1, SCN4B , (...)

View the complete list with 75 more genes
Specificity
2 %
Genes
9 %
Phosphorus Pan Cardiomyopathy Including Rasopathies and Recessive Pediatric Syndromes Panel.

By Phosphorus Diagnostics LLC in United States.

VCL, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, TNNT2, TPM1, JUP, DSG2, PLN, PRKAG2, TNNI3, TNNC1, TGFB3, ACTC1, RYR2, PKP2, ABCC9 , (...)

View the complete list with 57 more genes
Specificity
2 %
Genes
9 %
Phosphorus Pan Arrhythmia and Cardiomyopathy Including Recessive Pediatric Syndromes Panel.

By Phosphorus Diagnostics LLC in United States.

CALM3, SCN10A, VCL, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, TNNT2, TPM1, JUP, DSG2, PLN, PRKAG2, TNNI3, TNNC1, TGFB3, ACTC1, SCN4B , (...)

View the complete list with 58 more genes
Specificity
2 %
Genes
9 %
Phosphorus Hypertrophic Cardiomyopathy Including Rasopathies and Recessive Pediatric Syndromes Panel.

By Phosphorus Diagnostics LLC in United States.

VCL, ACTN2, TNNT2, TPM1, PLN, PRKAG2, TNNI3, TNNC1, ACTC1, A2ML1, RRAS, SPRED1, LAMP2, RASA1, CACNA1C, TCAP, FHL1, BAG3, LDB3, FLNC , (...)

View the complete list with 29 more genes
Specificity
3 %
Genes
9 %
BRCA1.

By Molecular Diagnostic Laboratory Kingston General Hospital in Canada.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1 & BRCA2 Seq and Del/Dup Analysis.

By Baylor Miraca Genetics Laboratories in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Prostate Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

CHEK2, NBN, TP53, BRCA2, BRCA1
Specificity
80 %
Genes
34 %
Comprehensive Hereditary Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

RAD51D, PMS1, ENG, BARD1, RAD51C, CDC73, PRKAR1A, PRF1, CEBPA, SBDS, PAX5, GATA2, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET , (...)

View the complete list with 41 more genes
Specificity
7 %
Genes
34 %
Breast & Ovarian Cancer, Familial (BRCA1 & BRCA2).

By Center for Human Genetics, Inc in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Comprehensive breast and ovarian cancer panel testing (18 genes).

By Molecular Genetics Laboratory North York General Hospital in Canada.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
17 %
Genes
25 %
BRCA1 and BRCA2 sequencing and deleetion/duplication analysis.

By Molecular Genetics Laboratory North York General Hospital in Canada.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary breast and ovarian cancer - full panel.

By CHEO Genetics Diagnostic Laboratory Children's Hospital of Eastern Ontario in Canada.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 and BRCA2, Full Exon Sequencing and Deletion/Duplication Analysis.

By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center in United States.

BRCA1
Specificity
100 %
Genes
9 %
Inherited Cancer Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

CDKN1B, BAP1, XRCC2, MITF, NF1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, CDKN2A, CDK4 , (...)

View the complete list with 29 more genes
Specificity
9 %
Genes
34 %
BRCA1 Targeted Analysis (BRCAssure).

By Molecular Diagnostic Laboratory LabCorp in United States.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1/2 Ashkenazi Jewish Profile (BRCAssure).

By Molecular Diagnostic Laboratory LabCorp in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1/2 Comprehensive Analysis (BRCAssure).

By Molecular Diagnostic Laboratory LabCorp in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
VistaSeq Hereditary Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

ABRAXAS1, RAD51D, BARD1, RAD51C, PRKAR1A, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
34 %
VistaSeq High/Moderate Risk Breast Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
34 %
Genes
25 %
VistaSeq GYN Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

CHEK2, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
28 %
Genes
25 %
Integrated BRACAnalysis.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
MultiSite 3 BRACAnalysis.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRACAnalysis CDx™.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Gastric Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

PDGFRA, KIT, CTNNA1, SMAD4, BMPR1A, STK11, CDH1, SDHB, SDHC, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
11 %
Genes
17 %
Comprehensive Hereditary Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DDX41, SAMD9L, SAMD9, POLE, ETV6, IKZF1, POLD1, SRP72, BAP1, TERT, TERC, NF1, RTEL1, CEBPA, PAX5, GATA2, BRIP1, SMAD4, BMPR1A, MAX , (...)

View the complete list with 34 more genes
Specificity
8 %
Genes
34 %
Hereditary Melanoma Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

WRN, POT1, ACD, POLE, BAP1, CDKN2A, CDK4, MC1R, TP53, BRCA2, BRCA1
Specificity
19 %
Genes
17 %
Hereditary Myeloid Malignancy and Inherited Bone Marrow Failure Panel.

By Genetic Services Laboratory University of Chicago in United States.

RAD51, UBE2T, SAMD9L, SAMD9, NAF1, POT1, DNAJC21, ACD, CXCR4, GFI1, RBM8A, RPL26, VPS45, G6PC3, RPL15, ELANE, CSF3R, ETV6, IKZF1, USB1 , (...)

View the complete list with 59 more genes
Specificity
6 %
Genes
34 %
Hereditary Breast and Ovarian Cancer High Risk Panel.

By Genetic Services Laboratory University of Chicago in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
17 %
BRCA1 and BRCA2 Mutation Analysis.

By Genetic Services Laboratory University of Chicago in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Comprehensive Hereditary Breast/Ovarian Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
17 %
Genes
25 %
Hereditary Breast and Ovarian Cancer Panel.

By Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital in New Zealand.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Cancer Panel - High Penetrance 16.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
19 %
Genes
25 %
Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA2) Sequencing and Deletion/Duplication.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA 2) Sequencing.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Comprehensive Cancer Panel.

By GeneDx in United States.

AXIN2, XRCC2, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, FANCC, TP53, PTEN, MUTYH , (...)

View the complete list with 9 more genes
Specificity
14 %
Genes
34 %
Breast Cancer High Risk Panel and PALB2.

By GeneDx in United States.

CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
34 %
Genes
17 %
Oncology High/Moderate Risk Panel.

By GeneDx in United States.

RAD51D, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC , (...)

View the complete list with 3 more genes
Specificity
14 %
Genes
25 %
Breast/Ovarian Cancer Panel.

By GeneDx in United States.

XRCC2, RAD51D, BARD1, RAD51C, BRIP1, CHEK2, CDH1, PALB2, NBN, ATM, FANCC, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
20 %
Genes
34 %
Endometrial Cancer Panel.

By GeneDx in United States.

POLD1, CHEK2, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
25 %
Genes
25 %
BRCA1/2 Sequencing and Del/Dup Analysis.

By GeneDx in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 and BRCA2 Sequencing.

By GeneDx in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Cancer Panel - Breast/Ovarian/Uterine26.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

ABRAXAS1, XRCC2, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, FANCC, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 6 more genes
Specificity
16 %
Genes
34 %
Hereditary Cancer Panel - Pancreatic14.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
15 %
Genes
17 %
Hereditary Cancer Panel - Breast/Ovarian17.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
18 %
Genes
25 %
BRCA Ashkenazi Jewish 3-mutation panel.

By Ambry Genetics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA Ashkenazi Jewish 3-mutation panel reflext to BRCA1/2 gene sequence and deletion/duplication.

By Ambry Genetics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 and BRCA2 gene sequence and deletion/duplication.

By Ambry Genetics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
CancerNext.

By Ambry Genetics in United States.

HOXB13, DICER1, POLE, GREM1, POLD1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 14 more genes
Specificity
15 %
Genes
42 %
CustomNext: Cancer.

By Ambry Genetics in United States.

NTHL1, HOXB13, GALNT12, DICER1, POT1, AIP, POLE, GREM1, POLD1, CDKN1B, BAP1, XRCC2, SMARCB1, SMARCA4, SMARCE1, MITF, NF1, RAD51D, BARD1, RAD51C , (...)

View the complete list with 48 more genes
Specificity
8 %
Genes
42 %
OvaNext.

By Ambry Genetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
34 %
ProstateNext.

By Ambry Genetics in United States.

HOXB13, RAD51D, CHEK2, PALB2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
36 %
Genes
42 %
PancNext.

By Ambry Genetics in United States.

CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
16 %
Genes
17 %
TumorNext-HRD+CancerNext.

By Ambry Genetics in United States.

HOXB13, DICER1, POLE, GREM1, POLD1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 14 more genes
Specificity
15 %
Genes
42 %
TumorNext-Lynch+CancerNext.

By Ambry Genetics in United States.

HOXB13, DICER1, POLE, GREM1, POLD1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 17 more genes
Specificity
14 %
Genes
42 %
TumorNext-HRD+OvaNext.

By Ambry Genetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
34 %
TumorNext-HRD.

By Ambry Genetics in United States.

RAD51D, BARD1, RAD51C, BRIP1, CHEK2, PALB2, NBN, MRE11, ATM, BRCA2, BRCA1
Specificity
37 %
Genes
34 %
TumorNext-Lynch+OvaNext.

By Ambry Genetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, NRAS, KRAS, TP53, PTEN, MUTYH , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
34 %
BRCA1. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1. MLPA testing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

BRCA1
Specificity
100 %
Genes
9 %
Hereditary Breast, Ovarian, and Endometrial Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

WRN, ITK, FANCA, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, ATM, MEN1, TP53, PTEN, MUTYH , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
34 %
Hereditary Melanoma Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

WRN, BAP1, TERT, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2, BRCA1
Specificity
20 %
Genes
17 %
Hereditary Pancreatic Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

PRSS1, SMAD4, BMPR1A, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
12 %
Genes
17 %
Hereditary Prostate Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

CHEK2, NBN, TP53, BRCA2, BRCA1
Specificity
80 %
Genes
34 %
Familial breast/ovarian cancer (deletion/duplication analysis of BRCA1 gene).

By CGC Genetics in Portugal.

BRCA1
Specificity
100 %
Genes
9 %
Familial breast/ovarian cancer (sequence analysis of BRCA1 and BRCA2 genes).

By CGC Genetics in Portugal.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Familial breast/ovarian cancer (sequence analysis of BRCA1 gene).

By CGC Genetics in Portugal.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer Test.

By Laboratory of Genetics HUSLAB in Finland.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 and BRCA2 Finnish founder mutations.

By Laboratory of Genetics HUSLAB in Finland.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Ovarian Cancer.

By Laboratory of Genetics HUSLAB in Finland.

RAD51, RAD51D, BARD1, RAD51C, BRIP1, RAD50, NBN, MRE11, TP53, BRCA2, BRCA1
Specificity
28 %
Genes
25 %
Fanconi Anemia Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

MAD2L2, RAD51, UBE2T, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2 , (...)

View the complete list with 1 more genes
Specificity
10 %
Genes
17 %
Pancreatic Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

PALLD, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
13 %
Genes
17 %
Hereditary Endometrial Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POLD1, CHEK2, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
25 %
Genes
25 %
Hereditary Breast and Ovarian Cancer - Expanded and Lynch Syndrome Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DICER1, XRCC2, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, FANCC, TP53, PTEN, MUTYH , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
34 %
Prostate Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

HOXB13, RAD51D, RAD51C, BRIP1, CHEK2, PALB2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
32 %
Genes
42 %
Comprehensive BRCA1 and BRCA2 seqeuncing, tumor specimens.

By Molecular Diagnostics Laboratory University Health Network in Canada.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Ovarian Cancer – Basic Diagnostics.

By MGZ Medical Genetics Center in Germany.

RAD51D, RAD51C, BRIP1, CHEK2, PALB2, NBN, TP53, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
31 %
Genes
34 %
Breast Cancer.

By MGZ Medical Genetics Center in Germany.

CEP57, BUB1B, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, NF1, RAD51D, RAD51C, BRIP1, CHEK2, SDHD, STK11, CDH1 , (...)

View the complete list with 17 more genes
Specificity
11 %
Genes
34 %
CentoBreast (hereditary breast cancer) panel.

By Centogene AG - the Rare Disease Company in Germany.

BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
31 %
Genes
34 %
Cancer Hotspot Panel.

By Centogene AG - the Rare Disease Company in Germany.

MYCL, ROS1, RPTOR, KIF5B, GNAI2, GNA13, EML4, BRD4, ARAF, NFE2L2, GNG2, KEAP1, NRG1, CCNE1, CD74, RICTOR, ERBB4, MYC, BCL6, SMO , (...)

View the complete list with 68 more genes
Specificity
3 %
Genes
17 %
Prostate cancer panel.

By Centogene AG - the Rare Disease Company in Germany.

HOXB13, CHEK2, NBN, TP53, PTEN, MLH1, MSH6, MSH2, BRCA2, BRCA1
Specificity
50 %
Genes
42 %
BRCA1 deletion/duplication testing.

By Michigan Medical Genetics Laboratories University of Michigan in United States.

BRCA1
Specificity
100 %
Genes
9 %
Hereditary Breast and Ovarian Cancer 1.

By Medical Genetics Laboratory Diagenom GmbH in Germany.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer.

By bio.logis Center for Human Genetics Diagnosticum in Germany.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Fanconi anemia Panel.

By CeGaT GmbH in Germany.

FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2, BRCA1
Specificity
13 %
Genes
17 %
Test for BRCA1 Hereditary Breast and Ovarian Cancer.

By All Wales Genetics Laboratory Institute of Medical Genetics in United Kingdom.

BRCA1
Specificity
100 %
Genes
9 %
Hereditary breast/ovarian cancer - analysis the BRCA1 gene mutations in accordance with EMQN recommendations.

By Laboratory of Human Genetics GENOMED Health Care Center in Poland.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1.

By Innovagenomics Innovagenomics S.L in Spain.

BRCA1
Specificity
100 %
Genes
9 %
Breast and Ovarian Cancer.

By Asper Biogene Asper Biogene LLC in Estonia.

CHD1, RAD51, XRCC2, FANCD2, FANCE, FANCF, FANCG, FANCA, RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, PALB2, NBN, MRE11, ATM, KRAS, FANCC , (...)

View the complete list with 9 more genes
Specificity
14 %
Genes
34 %
Ashkenazi Jewish diseases.

By Asper Biogene Asper Biogene LLC in Estonia.

F11, MEFV, CYP21A2, LRRK2, TOR1A, TMEM216, ABCC8, MCOLN1, SERPINA1, NEB, FKTN, SMN1, LDLR, GJB2, BLM, GBA, FANCC, CFTR, ELP1, ASPA , (...)

View the complete list with 17 more genes
Specificity
6 %
Genes
17 %
BRCA1 Hereditary Breast and Ovarian Cancer.

By Clinical Genomics Maastricht University Medical Centre in Netherlands.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1 Gene Sequencing.

By Advanced Molecular Diagnostics Mount Sinai Hospital in Canada.

BRCA1
Specificity
100 %
Genes
9 %
BRCA 1 and BRCA2 Gene Sequencing.

By GENETIX Centro de Investigación en Genética Humana y Reproductiva in Colombia.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Inherited Cancer Screen.

By Counsyl in United States.

POLE, GREM1, POLD1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, MRE11, ATM, SDHA , (...)

View the complete list with 16 more genes
Specificity
12 %
Genes
34 %
qCancer Risk.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53 , (...)

View the complete list with 10 more genes
Specificity
14 %
Genes
34 %
qCancer Risk Expanded.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLE, POLD1, MITF, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN2A, CDK4, STK11, CDH1 , (...)

View the complete list with 25 more genes
Specificity
9 %
Genes
34 %
qCancer Mama.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
34 %
Genes
25 %
qCancer Gine.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
17 %
Genes
34 %
Breast-Ovarian cancer, familial 1.

By MedGene in Slovakia.

BRCA1
Specificity
100 %
Genes
9 %
Invitae Breast Cancer Panel.

By Invitae in United States.

NF1, BARD1, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
34 %
Invitae Common Hereditary Cancers Panel (Breast, Gyn, GI).

By Invitae in United States.

DICER1, AXIN2, POLE, PDGFRA, GREM1, POLD1, KIT, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, SDHD, CDKN2A, STK11 , (...)

View the complete list with 22 more genes
Specificity
10 %
Genes
34 %
Invitae Multi-Cancer Panel.

By Invitae in United States.

DIS3L2, HOXB13, DICER1, WRN, POT1, AXIN2, POLE, PDGFRA, EGFR, GREM1, POLD1, CDKN1B, BAP1, KIT, SMARCB1, SMARCA4, SMARCE1, TERT, TERC, MITF , (...)

View the complete list with 60 more genes
Specificity
7 %
Genes
42 %
Invitae Breast Cancer Guidelines-Based Panel.

By Invitae in United States.

NF1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
37 %
Genes
34 %
Invitae Breast and Gyn Cancers Guidelines-Based Panel.

By Invitae in United States.

NF1, RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
22 %
Genes
34 %
Invitae Pancreatic Cancer Panel.

By Invitae in United States.

NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
10 %
Genes
17 %
Invitae Breast and Gyn Cancers Panel.

By Invitae in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2 , (...)

View the complete list with 3 more genes
Specificity
18 %
Genes
34 %
Invitae BRCA1 and BRCA2 STAT Panel.

By Invitae in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Breast and ovarian cancer, Hereditary: BRCA1 and BRCA2 genes deletions-duplications analysis (MLPA).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Breast and ovarian cancer, Hereditary: BRCA1 and BRCA2 genes screening (22 founder mutations in Spanish families).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
ONCOLOGY, PANEL.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

POLH, XPC, HOXB13, XPA, ERCC5, AIP, ELANE, PDGFRA, GREM1, ERCC4, CDKN1B, XRCC2, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA , (...)

View the complete list with 60 more genes
Specificity
7 %
Genes
42 %
COLON, BREAST AND OVARIAN CANCER.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

MLH3, AXIN2, XRCC2, NF1, RAD51D, PMS1, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, KRAS , (...)

View the complete list with 11 more genes
Specificity
13 %
Genes
34 %
BRCA - ovarian cancer, familial.

By Genome Diagnostics VU University Medical Center in Netherlands.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Cancer Syndrome: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BUB1B, AIP, POLD1, CDKN1B, BAP1, XRCC2, MGMT, SMARCB1, SMARCA4, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2 , (...)

View the complete list with 40 more genes
Specificity
7 %
Genes
34 %
Breast and Ovarian Cancer: Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

XRCC2, SMARCA4, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
17 %
Genes
34 %
Gastrointestinal and Colorectal Cancer: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
16 %
Genes
25 %
Gastrointestinal and Colorectal Cancer: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
16 %
Genes
25 %
Hereditary Cancer Syndrome: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BUB1B, POLD1, BAP1, XRCC2, SMARCB1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET, FLCN, SDHD , (...)

View the complete list with 35 more genes
Specificity
8 %
Genes
34 %
Pancreatic Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

BAP1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
15 %
Genes
17 %
BRCA1 and BRCA2 Full Gene Sequencing.

By Fulgent Genetics Fulgent Genetics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1.

By Fulgent Genetics Fulgent Genetics in United States.

BRCA1
Specificity
100 %
Genes
9 %
Focus Cancer Panel - 40 Genes.

By Fulgent Genetics Fulgent Genetics in United States.

RAD51, AXIN2, POLE, BAP1, KIT, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, MET, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 20 more genes
Specificity
10 %
Genes
34 %
Breast Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

BARD1, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
34 %
Endometrial Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

POLD1, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
20 %
Genes
17 %
Ovarian Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RAD51D, BARD1, RAD51C, BRIP1, STK11, NBN, MRE11, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
19 %
Genes
25 %
Pancreatic Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

NF1, SMAD4, BMPR1A, CDKN2A, CDK4, STK11, PALB2, ATM, TSC1, TSC2, FANCC, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL , (...)

View the complete list with 2 more genes
Specificity
10 %
Genes
17 %
Breast Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

XRCC2, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
23 %
Genes
34 %
Ovarian Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

SMARCA4, RAD51D, BARD1, RAD51C, BRIP1, STK11, NBN, MRE11, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
18 %
Genes
25 %
Prostate Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

HOXB13, CHEK2, NBN, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
46 %
Genes
42 %
breast cancer 1.

By Vanak Pathobiology Laboratory Vanak Pathobiology Laboratory in Iran.

BRCA1
Specificity
100 %
Genes
9 %
BRCAvantage, Rearrangements.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCAvantage, Comprehensive.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
MyVantage(TM) Hereditary Comprehensive Cancer Panel.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, SDHD, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, MEN1, SDHB , (...)

View the complete list with 14 more genes
Specificity
12 %
Genes
34 %
Hereditary Leukemia Panel.

By Blueprint Genetics in Finland.

DDX41, SAMD9L, ETV6, IKZF1, SRP72, FANCA, TERT, TERC, DKC1, NF1, CEBPA, SBDS, PAX5, GATA2, CDKN2A, NBN, ATM, CBL, MAP2K2, RIT1 , (...)

View the complete list with 19 more genes
Specificity
8 %
Genes
25 %
Comprehensive Hereditary Cancer Panel.

By Blueprint Genetics in Finland.

REST, PPM1D, EXO1, CD70, CEP57, ERCC1, MLH3, DDB2, DIS3L2, NTHL1, HOXB13, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, DDX41, SAMD9L , (...)

View the complete list with 126 more genes
Specificity
4 %
Genes
42 %
Hereditary Pancreatic Cancer Panel.

By Blueprint Genetics in Finland.

BUB1B, NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, FANCC, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL , (...)

View the complete list with 2 more genes
Specificity
10 %
Genes
17 %
Comprehensive Hematology Panel.

By Blueprint Genetics in Finland.

ARPC1B, MRTFA, GINS1, DCLRE1B, ERCC6L2, MTHFD1, AP3D1, SMARCD2, WDR1, LMAN1, MCFD2, RPS29, MECOM, TMPRSS6, F13B, SERPINC1, DHFR, F13A1, TF, F12 , (...)

View the complete list with 219 more genes
Specificity
2 %
Genes
25 %
Bone Marrow Failure Syndrome Panel.

By Blueprint Genetics in Finland.

ERCC6L2, SMARCD2, RPS29, DDX41, SAMD9L, SAMD9, DNAJC21, PGM3, ACD, JAGN1, WIPF1, CXCR4, RAC2, LAMTOR2, GFI1, RBM8A, VPS45, G6PC3, RPL15, ITK , (...)

View the complete list with 102 more genes
Specificity
3 %
Genes
25 %
Hereditary Gastrointestinal Cancer Panel.

By Blueprint Genetics in Finland.

NTHL1, RHBDF2, BUB1B, AXIN2, POLE, PDGFRA, GREM1, POLD1, KIT, SMARCB1, NF1, SMAD4, BMPR1A, SDHD, CDKN2A, STK11, CDH1, PALB2, ATM, TSC1 , (...)

View the complete list with 19 more genes
Specificity
6 %
Genes
17 %
Hereditary Breast and Gynecological Cancer Panel.

By Blueprint Genetics in Finland.

DICER1, XRCC2, FANCM, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, BLM, TP53, PTEN , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
34 %
Hereditary Melanoma and Skin Cancer Panel.

By Blueprint Genetics in Finland.

DDB2, XPC, XPA, ERCC5, WRN, POT1, ERCC4, BAP1, MITF, ERCC3, ERCC2, CDKN2A, CDK4, SUFU, PTCH1, TP53, PTEN, BRCA2, BRCA1
Specificity
11 %
Genes
17 %
Hereditary Breast Cancer High Risk Panel.

By Blueprint Genetics in Finland.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
17 %
Hereditary Pancreatic Cancer Core Panel.

By Blueprint Genetics in Finland.

CDKN2A, STK11, PALB2, BRCA2, BRCA1
Specificity
40 %
Genes
17 %
BRCATRUE™.

By Pathway Genomics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BreastTrue.

By Pathway Genomics in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
17 %
BRCAtrue Ashkenazi Jewish.

By Pathway Genomics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Focus::BRCA™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Solid Tumor Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

BCL2L1, H3F3A, KLF4, TRAF7, PIK3C2B, HIST1H3B, JAK1, MCL1, PBRM1, DAXX, CDKN1A, MYB, MYBL1, RAD54B, ESR2, ESR1, KMT2C, FGFR4, ROS1, NFE2L2 , (...)

View the complete list with 102 more genes
Specificity
3 %
Genes
25 %
Head & Neck Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

RHOA, BCL2L1, PIK3C2B, MCL1, KMT2C, NFE2L2, RAC1, FAT1, AFF3, ERBB2, CCND1, NOTCH2, PIK3R1, AKT1, AKT3, FBXW7, EGFR, AKT2, PIK3CA, GATA4 , (...)

View the complete list with 21 more genes
Specificity
5 %
Genes
17 %
Hereditary breast and ovarian cancer risk.

By Genomic Engenharia Molecular in Brazil.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 and BRCA2 Sequencing.

By ApolloGen, Inc. in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
iGene Cancer Panel.

By ApolloGen, Inc. in United States.

NF1, RAD51C, BRIP1, SMAD4, BMPR1A, CDKN2A, STK11, CDH1, PALB2, PTCH1, NBN, ATM, MEN1, RET, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 5 more genes
Specificity
12 %
Genes
25 %
FoundationOne® Heme.

By Foundation Medicine, Inc. in United States.

TRAF5, PIM1, PRDM1, HIST1H2AG, HIST1H3B, HIST1H1C, HDAC1, GTSE1, HIST1H1D, HIST1H2BK, HIST1H2BO, HIST1H2BC, HIST1H2AC, HIST1H2AM, HIST1H1E, HIST1H2AL, HDAC7, HIST1H2BJ, INPP5D, IKZF2 , (...)

View the complete list with 385 more genes
Specificity
1 %
Genes
25 %
Hereditary Breast and Ovarian Cancer 26 Gene Panel.

By Veritas Genetics Veritas Genetics in United States.

ABRAXAS1, XRCC2, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, MEN1, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
34 %
BRCA 1 and BRCA2 Gene Sequencing.

By Center for Comprehensive Genetic Services Shahid Beheshti University of Medical Sciences in Iran.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 Mutation & Del/Dup Analysis.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1/2 Mutation & Del/Dup Analysis.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Cancer Comprehensive Panel.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

TP53BP1, KLLN, CHEK1, GEN1, MYH15, MYH1, MYH13, MYH4, PPM1D, HOXB13, MYH10, GALNT12, RAD51, AKT1, POLE, ABRAXAS1, ETV6, GREM1, POLD1, PIK3CA , (...)

View the complete list with 53 more genes
Specificity
7 %
Genes
42 %
NeoTYPE® Discovery Profile for Solid Tumors.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

IKBKE, INPP4B, HSP90AA1, LRP1B, BCL2L2, AURKB, LMO1, ARFRP1, MDM4, MAP2K4, MCL1, EMSY, CHEK1, PBRM1, DAXX, PDCD1LG2, EPHB1, EPHA3, DOT1L, EPHA5 , (...)

View the complete list with 295 more genes
Specificity
1 %
Genes
25 %
Caris MI TumorSeek 592-Gene NGS Panel.

By Caris Life Sciences in United States.

ETV1, BCL3, SET, ELL, BTG1, ADGRA2, ACSL3, AFF1, ACSL6, ACKR3, RABEP1, PSIP1, RANBP17, RAD51B, RPL22, SDC4, SH3GL1, REL, SLC45A3, SYK , (...)

View the complete list with 571 more genes
Specificity
1 %
Genes
34 %
BRCA Test.

By Color Genomics, Inc. Color Genomics, Inc. in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
OmniSeq Comprehensive.

By OmniSeq, Inc. in United States.

NKX2-8, RHOA, BCL2L1, ETV4, ETV1, GAS6, RPS6KB1, RHEB, SPOP, TIAF1, XPO1, ZNF217, JAK1, KNSTRN, IFITM1, APEX1, ATP11B, MDM4, BCL9, BIRC2 , (...)

View the complete list with 124 more genes
Specificity
3 %
Genes
25 %
BREAST AND OVARIAN CANCER.

By Laboratorio de Genetica Clinica SL in Spain.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Breast and Ovarian Hereditary Cancer , Panel Massive Sequencing (NGS) 20 Genes.

By Reference Laboratory Genetics in Spain.

NF1, RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
20 %
Genes
34 %
genTrue.

By True Health Diagnostics in United States.

POLE, POLD1, RAD51D, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 6 more genes
Specificity
16 %
Genes
34 %
Phosphorus Prostate Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

HOXB13, RAD51D, CHEK2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
39 %
Genes
42 %
152 Integrated Advantage NGS Solid Tumor Panel.

By Integrated Molecular Diagnostics Pathology, Inc. in United States.

AURKA, TOP1, ABCC1, SLC29A1, STK11IP, SYK, SULT1A1, XRCC1, TOP2A, TOP2B, PLK1, JAK1, JUN, IKBKE, BCL2L2, AURKB, MDM4, MAP2K4, EMSY, CHEK1 , (...)

View the complete list with 132 more genes
Specificity
2 %
Genes
25 %
Breast and Ovarian Cancer: Sequencing and Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

XRCC2, SMARCA4, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
17 %
Genes
34 %
CEN4GEN Comprehensive Hereditary Cancer Syndrome: Gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

RAD51B, EHBP1, POU6F2, EPHB2, MSMB, ASCC1, MSR1, XRCC3, PTCH2, PALLD, MLH3, DDB2, DIS3L2, MTAP, POLH, UROD, TMC8, TMC6, PDE11A, XPC , (...)

View the complete list with 123 more genes
Specificity
6 %
Genes
67 %
Gastrointestinal and Colorectal Cancer: gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
16 %
Genes
25 %
Gastrointestinal and Colorectal Cancer: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
16 %
Genes
25 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Gene Sequencing and Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Melanoma: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WRN, BAP1, MGMT, KIT, CDKN2A, CDK4, NRAS, RB1, TP53, PTEN, BRCA1
Specificity
10 %
Genes
9 %
Prostate cancer: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

CHEK2, NBN, TP53, BRCA2, BRCA1
Specificity
80 %
Genes
34 %
Hereditary Cancer Syndrome: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, AIP, POLD1, CDKN1B, BAP1, XRCC2, MGMT, SMARCB1, SMARCA4, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2 , (...)

View the complete list with 40 more genes
Specificity
7 %
Genes
34 %
Hereditary Cancer Syndrome: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, POLD1, BAP1, XRCC2, SMARCB1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET, FLCN, SDHD , (...)

View the complete list with 35 more genes
Specificity
8 %
Genes
34 %
BRCA1 & BRCA2 Seq and Del/Dup Analysis.

By Baylor Miraca Genetics Laboratories in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary High Risk Breast Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
17 %
Hereditary High Risk Breast Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
17 %
Hereditary Pancreatic Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

RAD50, SMAD4, BMPR1A, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
12 %
Genes
17 %
Hereditary Colorectal/Gastrointestinal Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

PMS1, ENG, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC , (...)

View the complete list with 2 more genes
Specificity
14 %
Genes
25 %
Breast-ovarian cancer, familial 1 (BRCA1).

By Center for Human Genetics, Inc in United States.

BRCA1
Specificity
100 %
Genes
9 %
Comprehensive breast cancer panel testing (10 genes).

By Molecular Genetics Laboratory North York General Hospital in Canada.

BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
30 %
Genes
25 %
Hereditary breast and ovarian cancer - familial variant analysis.

By CHEO Genetics Diagnostic Laboratory Children's Hospital of Eastern Ontario in Canada.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Breast Cancer Predisposition, (BRCA1, BRCA2, TP53, CHEK2, PALB2, CDH1, PTEN, STK11, ATM), Mutation, Deletion/Duplication Analysis.

By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
17 %
Inherited Breast Cancer.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

CHEK2, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
43 %
Genes
25 %
Inherited Ovarian Cancer.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
29 %
Genes
17 %
BRCA1/2 Deletion/Duplication Analysis (BRCAssure).

By Molecular Diagnostic Laboratory LabCorp in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
VisaSeq Breast and GYN Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

ABRAXAS1, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, FANCC, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
34 %
VistaSeq Breast Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

ABRAXAS1, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, BRCA2, BRCA1
Specificity
22 %
Genes
34 %
VistaSeq Pancreatic Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
15 %
Genes
17 %
VistaSeq Colorectal Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

AXIN2, POLE, POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC , (...)

View the complete list with 2 more genes
Specificity
14 %
Genes
25 %
myRisk Hereditary Cancer.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

POLE, GREM1, POLD1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH , (...)

View the complete list with 8 more genes
Specificity
15 %
Genes
34 %
BRCA1 Gene Analysis.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1 Single Mutation Analysis.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA1
Specificity
100 %
Genes
9 %
Tier 2: Hereditary Lymphoma and Immunodeficiency Panel.

By Genetic Services Laboratory University of Chicago in United States.

CARD11, CTLA4, CD27, PIK3CD, ITK, STXBP2, CASP10, FASLG, FAS, TNFRSF13B, IKZF1, SH2D1A, DOCK8, MAGT1, NF1, WAS, PRF1, NBN, ATM, BLM , (...)

View the complete list with 3 more genes
Specificity
14 %
Genes
25 %
Tier 2: Familial Myelodysplastic Syndrome/Acute Leukemia (MDS/AL) Panel.

By Genetic Services Laboratory University of Chicago in United States.

NF1, CHEK2, ATM, CBL, PTPN11, BLM, TP53, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
24 %
Genes
25 %
Familial BRCA1 and BRCA2 mutation analysis.

By Genetic Services Laboratory University of Chicago in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
3 Ashkenazi BRCA1 and BRCA2 mutation analysis.

By Genetic Services Laboratory University of Chicago in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Leukemia and Breast Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DDX41, SAMD9L, SAMD9, ETV6, IKZF1, SRP72, TERT, TERC, NF1, RTEL1, CEBPA, PAX5, GATA2, CHEK2, CDH1, PALB2, NBN, ATM, CBL, PTPN11 , (...)

View the complete list with 11 more genes
Specificity
13 %
Genes
34 %
BRCA1, BRCA2, and PALB2 Mutation Analysis.

By Genetic Services Laboratory University of Chicago in United States.

PALB2, BRCA2, BRCA1
Specificity
67 %
Genes
17 %
BRCA1, BRCA2, and TP53 Mutation Analysis.

By Genetic Services Laboratory University of Chicago in United States.

TP53, BRCA2, BRCA1
Specificity
67 %
Genes
17 %
Comprehensive BRCA1/BRCA2 Testing.

By United States Air Force Molecular Diagnostic Laboratory United States Air Force in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 Hereditary Breast and Ovarian Cancer.

By Molecular Genetics Rabin Medical Center in Israel.

BRCA1
Specificity
100 %
Genes
9 %
Breast Cancer BRCA1.

By Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital in New Zealand.

BRCA1
Specificity
100 %
Genes
9 %
Hereditary Breast and Ovarian Cancer.

By Institute of Human Genetics Universitätsmedizin Greifswald in Germany.

RAD51C, CHEK2, PALB2, BRCA2, BRCA1
Specificity
60 %
Genes
25 %
BRCA1.

By Institute for Human Genetics University Clinic Freiburg in Germany.

BRCA1
Specificity
100 %
Genes
9 %
Breast Cancer-Predisposition Genes.

By Service de Génétique Gustave Roussy in France.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1-Hereditary Cancer of the Breast.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

BRCA1
Specificity
100 %
Genes
9 %
Hereditary Cancer Panel Comprehensive.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

POLE, GREM1, POLD1, CTNNA1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, SDHB, TP53 , (...)

View the complete list with 10 more genes
Specificity
14 %
Genes
34 %
Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 20 Genes.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, MEN1, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, BRCA2, BRCA1
Specificity
20 %
Genes
34 %
Cancer Panel, Hereditary, Sequencing 46 Genes, Deletion/Duplication, 47 Genes.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

CDKN1B, BAP1, SMARCB1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN2A, CDK4, STK11, CDH1, SUFU, PALB2 , (...)

View the complete list with 27 more genes
Specificity
9 %
Genes
34 %
Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA2) Deletion/Duplication.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Breast Cancer High/Moderate Risk Panel.

By GeneDx in United States.

CHEK2, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
38 %
Genes
25 %
Breast Cancer High Risk Panel.

By GeneDx in United States.

CDH1, TP53, PTEN, BRCA2, BRCA1
Specificity
40 %
Genes
17 %
Pancreatic Cancer Panel.

By GeneDx in United States.

XRCC2, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
13 %
Genes
17 %
OncoGeneDx Custom Panel.

By GeneDx in United States.

AXIN2, XRCC2, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, FANCC, TP53, PTEN, MUTYH , (...)

View the complete list with 9 more genes
Specificity
14 %
Genes
34 %
BRCA1 and BRCA2 Del/Dup.

By GeneDx in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Cancer Panel - Breast9.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
34 %
Genes
25 %
BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer.

By Sheffield Diagnostic Genetics Service Sheffield Children's NHS Foundation Trust in United Kingdom.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCAplus.

By Ambry Genetics in United States.

CHEK2, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
38 %
Genes
25 %
BreastNext.

By Ambry Genetics in United States.

NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, BRCA2, BRCA1
Specificity
24 %
Genes
34 %
CancerNext-Expanded.

By Ambry Genetics in United States.

HOXB13, GALNT12, DICER1, POT1, POLE, GREM1, POLD1, CDKN1B, BAP1, XRCC2, SMARCB1, SMARCA4, SMARCE1, MITF, NF1, RAD51D, BARD1, RAD51C, PRKAR1A, BRIP1 , (...)

View the complete list with 44 more genes
Specificity
8 %
Genes
42 %
TumorNext-BRCA.

By Ambry Genetics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
GYNplus.

By Ambry Genetics in United States.

RAD51D, RAD51C, BRIP1, PALB2, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
16 %
Genes
17 %
BRCA1, BRCA2. MLPA testing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1, BRCA2. NextGeneDx.Complete sequencing by NGS.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary High-Risk Breast Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
17 %
Hereditary Colorectal and Gastrointestinal Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

POLE, POLD1, KIT, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 3 more genes
Specificity
14 %
Genes
25 %
CHOP Comprehensive Hereditary Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

DDB2, DIS3L2, MTAP, CEBPE, POLH, ARID5B, HMBS, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, DDX41, COL7A1, G6PC3, ITK, ELANE, EXT1, EXT2 , (...)

View the complete list with 86 more genes
Specificity
4 %
Genes
34 %
Breast cancer (NGS panel for 10 genes).

By CGC Genetics in Portugal.

RAD51D, RAD51C, BRIP1, CHEK2, CDH1, PALB2, ATM, TP53, BRCA2, BRCA1
Specificity
30 %
Genes
25 %
Breast cancer (NGS panel for 18 genes).

By CGC Genetics in Portugal.

ERCC4, RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
17 %
Genes
25 %
Pancreatic familial carcinoma (sequence analysis of BRCA1 and BRCA2 genes).

By CGC Genetics in Portugal.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Pancreatic cancer (NGS panel for 3 genes).

By CGC Genetics in Portugal.

PALB2, BRCA2, BRCA1
Specificity
67 %
Genes
17 %
Familial breast/ovarian cancer (deletion/duplication analysis of BRCA1 and BRCA2 genes).

By CGC Genetics in Portugal.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Breast cancer (mutations 187delAG(BRCA1), 5385insC(BRCA1), 6174delT(BRCA2)).

By CGC Genetics in Portugal.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
OncoRisk (NGS panel for 48 genes).

By CGC Genetics in Portugal.

EXT1, EXT2, FANCA, FANCB, NF1, RAD51C, CDC73, PRKAR1A, CEBPA, BRIP1, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN1C, CDKN2A, CDK4 , (...)

View the complete list with 28 more genes
Specificity
9 %
Genes
34 %
OncoRisk Plus (NGS panel for 89 genes).

By CGC Genetics in Portugal.

CEP57, DDB2, DIS3L2, XPC, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, ERCC4, BAP1, FANCD2, FANCI, FANCL, FANCM, SLX4 , (...)

View the complete list with 69 more genes
Specificity
5 %
Genes
34 %
Familial breast/ovarian cancer (deletion/duplication analysis and sequence analysis of BRCA1 and BRCA2 genes).

By CGC Genetics in Portugal.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Breast and Ovarian Cancer BRCA1/2 Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, MEN1, RET, TP53 , (...)

View the complete list with 11 more genes
Specificity
13 %
Genes
34 %
Breast Cancer - Comprehensive Risk Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

RECQL, NF1, RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, BRCA2, BRCA1
Specificity
23 %
Genes
34 %
Breast Cancer - High Risk Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
34 %
Genes
17 %
Breast Cancer - High / Moderate Risk Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
34 %
Genes
25 %
Hereditary Ovarian Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2 , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
34 %
Hereditary Breast and Ovarian Cancer - High Risk and Lynch Syndrome Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
18 %
Genes
25 %
Breast Cancer – Basic Diagnostics.

By MGZ Medical Genetics Center in Germany.

RAD51D, RAD51C, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
28 %
Genes
25 %
BRCA.

By MGZ Medical Genetics Center in Germany.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 Hereditary Breast and Ovarian Cancer.

By MGZ Medical Genetics Center in Germany.

BRCA1
Specificity
100 %
Genes
9 %
Hereditary Cancer Syndromes - panels.

By MGZ Medical Genetics Center in Germany.

RNF43, CEP57, DDB2, DIS3L2, XPC, NTHL1, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, AXIN2, POLE, EGFR, GREM1 , (...)

View the complete list with 80 more genes
Specificity
4 %
Genes
34 %
Ovarian Cancer.

By MGZ Medical Genetics Center in Germany.

CEP57, BUB1B, DICER1, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51D, RAD51C, BRIP1, CHEK2, PALB2, NBN, ATM, FANCC , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
34 %
BRCA1 Hereditary Breast and Ovarian Cancer.

By Bioscientia GmbH Center for Human Genetics in Germany.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1.

By GeneTech ATS GeneTech Private Limited in India.

BRCA1
Specificity
100 %
Genes
9 %
Breast cancer panel.

By Genome Diagnostics Laboratory University Medical Center Utrecht in Netherlands.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
CentoCancer panel.

By Centogene AG - the Rare Disease Company in Germany.

NTHL1, POLE, POLD1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, FLCN, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, BLM, FH , (...)

View the complete list with 11 more genes
Specificity
13 %
Genes
34 %
Breast cancer.

By Centogene AG - the Rare Disease Company in Germany.

BRCA1
Specificity
100 %
Genes
9 %
BRCA Ashkenazi Jewish 3 founder mutation testing.

By Michigan Medical Genetics Laboratories University of Michigan in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 and BRCA2 mutation panel.

By Michigan Medical Genetics Laboratories University of Michigan in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 full gene sequencing.

By Michigan Medical Genetics Laboratories University of Michigan in United States.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1 y BRCA2 Perfil Colombia.

By Instituto de Referencia Andino in Colombia.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 mutations.

By Medical Genetics Institute Shaare Zedek Medical Center in Israel.

BRCA1
Specificity
100 %
Genes
9 %
Pancreatic cancer Panel.

By CeGaT GmbH in Germany.

PALLD, PRSS1, SPINK1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
12 %
Genes
17 %
Breast and Ovarian Cancer - extended Diagnostic Panel.

By CeGaT GmbH in Germany.

UIMC1, RINT1, MSH3, ABRAXAS1, XRCC2, FANCD2, SLX4, FANCE, FANCF, FANCG, FANCA, NF1, RAD51D, PMS1, BARD1, RAD51C, BRIP1, RAD50, CHEK2, SDHD , (...)

View the complete list with 21 more genes
Specificity
10 %
Genes
34 %
Breast and Ovarian Cancer Panel.

By CeGaT GmbH in Germany.

RAD51D, RAD51C, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
28 %
Genes
25 %
BRCA1 Hereditary Breast and Ovarian Cancer.

By GGA - Galil Genetic Analysis in Israel.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1.

By ProntoLab - MLPA Lab Pronto Diagnostics Ltd. in Israel.

BRCA1
Specificity
100 %
Genes
9 %
Cancer Predisposition.

By Asper Biogene Asper Biogene LLC in Estonia.

DDB2, DIS3L2, XPC, RHBDF2, CYLD, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, EGFR, ERCC4, BAP1, FANCD2, FANCI, FANCL, FANCM, SLX4 , (...)

View the complete list with 69 more genes
Specificity
5 %
Genes
34 %
BRCA1 sequencing.

By Molecular Diagnostics Laboratory Seoul National University Hospital in South Korea.

BRCA1
Specificity
100 %
Genes
9 %
Hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, TP53, PALB2, CHEK2).

By Center for Human Genetics Cliniques Universitaires Saint Luc in Belgium.

CHEK2, PALB2, TP53, BRCA2, BRCA1
Specificity
60 %
Genes
25 %
BRCA1 Deletion Duplication (MLPA).

By Advanced Molecular Diagnostics Mount Sinai Hospital in Canada.

BRCA1
Specificity
100 %
Genes
9 %
Breast-Ovarian cancer, familial 1.

By Praxis fuer Humangenetik Wien in Austria.

BRCA1
Specificity
100 %
Genes
9 %
BRCA1 and BRCA2 deletion/duplication analysis.

By GENETIX Centro de Investigación en Genética Humana y Reproductiva in Colombia.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 Hereditary Breast and Ovarian Cancer.

By Department of Clinical Genetics St. Elisabeth Cancer Institute in Slovakia.

BRCA1
Specificity
100 %
Genes
9 %
qCancer BRCAs.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Invitae Prostate Cancer Panel.

By Invitae in United States.

HOXB13, CHEK2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
42 %
Genes
42 %
Invitae Breast Cancer STAT Panel.

By Invitae in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
17 %
Invitae Hereditary Breast and Ovarian Cancer Syndrome Panel.

By Invitae in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Breast and ovarian cancer, Hereditary- BRCA1 and BRCA2 genes sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Breast and ovarian cancer, Hereditary: BRCA1 gene deletions-duplications analysis (MLPA).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA1
Specificity
100 %
Genes
9 %
Breast and ovarian cancer, Hereditary: BRCA1 gene screening (founder mutations in Spanish families ).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA1
Specificity
100 %
Genes
9 %
Breast and ovarian cancer, Hereditary: BRCA1 gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA1
Specificity
100 %
Genes
9 %
Breast and ovarian cancer, Hereditary: BRCA1 gene sequence analysis and deletions-duplications analysis (MLPA).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA1
Specificity
100 %
Genes
9 %
BRCA - breast cancer, familial.

By Genome Diagnostics VU University Medical Center in Netherlands.

CHEK2, BRCA2, BRCA1
Specificity
100 %
Genes
25 %
BRCA - pancreatic cancer.

By Genome Diagnostics VU University Medical Center in Netherlands.

PALB2, BRCA2, BRCA1
Specificity
67 %
Genes
17 %
High Risk Breast Cancer: Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
17 %
Pancreatic Cancer: Sequencing Panel and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BAP1, PRSS1, SMAD4, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
14 %
Genes
17 %
Ashkenazi Jewish: BRCA Targeted Mutation Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Gene Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Gene Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 and BRCA2 genes sequence analysis: Hereditary Breast and Ovarian Cancer.

By DLE - Diagnosticos Laboratoriais Especializados in Brazil.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Melanoma NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

WRN, TERT, MITF, ERCC3, CDKN2A, CDK4, TYR, MC1R, RB1, TP53, PTEN, BRCA2, BRCA1
Specificity
16 %
Genes
17 %
Hereditary Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RBM15, EXO1, XRCC3, PICALM, ROBO2, MSH3, DDB2, XPC, HOXB13, CYLD, GALNT12, BUB1B, RAD51, XPA, ERCC5, DICER1, EGLN1, WRN, PRKDC, AIP , (...)

View the complete list with 92 more genes
Specificity
5 %
Genes
42 %
BRCA1 and BRCA2 Deletion/Duplication Analysis.

By Fulgent Genetics Fulgent Genetics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Prostate Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

CHEK2, NBN, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
40 %
Genes
34 %
Comprehensive Cancer Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RBM15, EXO1, XRCC3, PICALM, ROBO2, MSH3, DDB2, DIS3L2, XPC, HOXB13, CYLD, GALNT12, BUB1B, RAD51, XPA, ERCC5, DICER1, EGLN1, WRN, PRKDC , (...)

View the complete list with 104 more genes
Specificity
5 %
Genes
42 %
Endometrial Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

POLD1, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
20 %
Genes
17 %
BRCAvantage, Ashkenazi Jewish Screen.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BREASTON.

By PentaCoreLab in Hungary.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BREASTON-EXTENDED.

By PentaCoreLab in Hungary.

DIRAS3, ERBB2, RAD51, BARD1, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, ATM, KRAS, TP53, BRCA2, BRCA1
Specificity
25 %
Genes
34 %
Hemato-oncology chromosomal microarray.

By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center in United States.

NUTM2B, NUTM2A, SSX2, MALAT1, ETV4, TFEB, SSX4, NR4A3, MSI2, CREB3L2, TFE3, FOXO1, ETV1, ACSL3, RABEP1, SSX1, SS18, POU5F1, HEY1, JUN , (...)

View the complete list with 72 more genes
Specificity
3 %
Genes
17 %
Hereditary Cancer High Risk Panel.

By Blueprint Genetics in Finland.

POLE, POLD1, BAP1, RAD51D, RAD51C, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, ATM, MEN1, RET, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 8 more genes
Specificity
11 %
Genes
25 %
BRCA 1 and BRCA2 Gene Sequencing.

By Genomic Research Center Shahid Beheshti University of Medical Sciences in Iran.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Focus::HERSite® NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
19 %
Genes
25 %
Hereditary breast�¢����ovarian cancer syndrome type 1.

By Bioarray in Spain.

BRCA1
Specificity
100 %
Genes
9 %
Breast Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

RAD54B, ESR2, ESR1, RAC1, ERBB4, ERBB2, KDR, CDK6, PIK3R1, AKT1, FBXW7, IDH1, EGFR, PIK3CA, FANCA, KIT, ERBB3, GATA3, FGFR1, BRIP1 , (...)

View the complete list with 22 more genes
Specificity
8 %
Genes
25 %
Genitourinary Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

PBRM1, CDKN1A, KMT2C, RXRA, ERBB2, PIK3R1, AKT1, AKT3, FBXW7, STAG2, EGFR, AKT2, PIK3CA, BAP1, ERBB3, TERT, KDM6A, MTOR, MED12, ERCC2 , (...)

View the complete list with 24 more genes
Specificity
5 %
Genes
17 %
Gynecologic Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

ERBB4, PPP2R1A, FAT1, SMO, ERBB2, CDK12, CCND1, KDR, PIK3R1, AKT1, AKT3, PIK3R2, POLE, FBXW7, ABL1, EGFR, AKT2, POLD1, PIK3CA, JAK3 , (...)

View the complete list with 30 more genes
Specificity
4 %
Genes
17 %
BRCA ashkenazi.

By Laboratorio de Patologia Integral y Diagnostico Oportuno Laboratorio de Patologia Integral y Diagnostico Oportuno in Mexico.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Exome.

By DNA CONSULT GENETICA E BIOTECNOLOGIA LTDA. in Brazil.

IPW, SMNDC1, GEMIN2, HERC2, ATXN8, CYP2C9, IL1RN, CCDC88C, VKORC1, CYP2D6, CYP2C19, F8, F9, MAGEL2, SOX9, RPL10, PTCHD1, SEMA3E, SHANK2, KCND3 , (...)

View the complete list with 46 more genes
Specificity
4 %
Genes
17 %
Breast Cancer Panel.

By ApolloGen, Inc. in United States.

RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MLH1, MSH6, MSH2, BRCA2, BRCA1
Specificity
27 %
Genes
34 %
Genetic Test of single known genetic variant.

By National Taiwan University Hospital A1 Center National Taiwan University Hospital in Taiwan.

GNAS, PKD1, PKD2, TSC1, TSC2, MEN1, RET, TP53, BRCA2, BRCA1
Specificity
20 %
Genes
17 %
Guardant360.

By Guardant Health in United States.

MAPK3, RHOA, RHEB, MAPK1, ESR1, NTRK3, ROS1, ARAF, NFE2L2, CCNE1, MYC, SMO, ERBB2, DDR2, CCND1, CDK6, CCND2, AKT1, GNA11, FBXW7 , (...)

View the complete list with 53 more genes
Specificity
3 %
Genes
17 %
Hereditary Breast and Ovarian Cancer BRCA1&2.

By GeneKor MSA in Greece.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1 and BRCA2 gene analysis.

By Veritas Genetics Veritas Genetics in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA Panel.

By Castle Medical Molecular Diagnostics Castle Medical, LLC in United States.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA1.

By Caris Life Sciences in United States.

BRCA1
Specificity
100 %
Genes
9 %
Hereditary Cancer.

By Color Genomics, Inc. Color Genomics, Inc. in United States.

POLE, GREM1, POLD1, BAP1, MITF, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN , (...)

View the complete list with 9 more genes
Specificity
14 %
Genes
34 %
Breast and Ovarian Hereditary Cancer, Deletions-Duplications (MLPA) BRCA1 Gene.

By Reference Laboratory Genetics in Spain.

BRCA1
Specificity
100 %
Genes
9 %
Oncology Genetic Panel , Panel Massive Sequencing (NGS) 90 Genes.

By Reference Laboratory Genetics in Spain.

CEP57, DDB2, DIS3L2, XPC, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, EGFR, ERCC4, BAP1, FANCD2, FANCI, FANCL , (...)

View the complete list with 70 more genes
Specificity
5 %
Genes
34 %
Breast and Ovarian Hereditary Cancer, Sequencing BRCA1 Gene.

By Reference Laboratory Genetics in Spain.

BRCA1
Specificity
100 %
Genes
9 %
Breast and Ovarian Hereditary Cancer , Panel Massive Sequencing and Deletions-Duplications(NGS) BRCA1 and BRCA2 Genes.

By Reference Laboratory Genetics in Spain.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
Breast and Ovarian Hereditary Cancer , Panel Massive Sequencing (NGS) BRCA1,BRCA2,TP53,PALB2 Genes.

By Reference Laboratory Genetics in Spain.

PALB2, TP53, BRCA2, BRCA1
Specificity
50 %
Genes
17 %
Familial Pancreatic Cancer , Panel Massive Sequencing (NGS) 16 Genes.

By Reference Laboratory Genetics in Spain.

MLH3, TGFBR2, SMAD4, CDKN2A, STK11, PALB2, KRAS, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
13 %
Genes
17 %
Familial cancer of breast.

By Labor Dr. Wisplinghoff in Germany.

CHEK2, PALB2, BRCA2, BRCA1
Specificity
75 %
Genes
25 %
Phosphorus Breast Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

NF1, RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
27 %
Genes
34 %
Phosphorus Ovarian/Uterine Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DICER1, SMARCA4, RAD51D, RAD51C, BRIP1, PALB2, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
14 %
Genes
17 %
Phosphorus Pancreatic Cancer including Chronic Pancreatitis Genes Panel.

By Phosphorus Diagnostics LLC in United States.

CTRC, PRSS1, SPINK1, CASR, NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, CFTR, MEN1, TP53, MLH1, MSH6, PMS2, MSH2 , (...)

View the complete list with 5 more genes
Specificity
8 %
Genes
17 %
Phosphorus Pancreatic Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
10 %
Genes
17 %
Phosphorus Pan-Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DIS3L2, HOXB13, DICER1, WRN, POT1, AIP, AXIN2, POLE, PDGFRA, EGFR, GREM1, POLD1, CDKN1B, BAP1, XRCC2, KIT, SMARCB1, SMARCA4, SMARCE1, TERT , (...)

View the complete list with 63 more genes
Specificity
7 %
Genes
42 %
Phosphorus Common/High Risk Cancers Panel.

By Phosphorus Diagnostics LLC in United States.

POLE, GREM1, POLD1, BAP1, MITF, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM , (...)

View the complete list with 12 more genes
Specificity
13 %
Genes
34 %
CEN4GEN Breast cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WEE1, ACVR1B, PTGFR, ZBED4, ZNF226, TRAF5, PPM1L, MAP2K4, PCGF2, PBRM1, FBXO32, EXOC2, NCOR1, MUC16, ESR1, KMT2C, ITCH, MYC, CBFB, ERBB2 , (...)

View the complete list with 25 more genes
Specificity
5 %
Genes
17 %
CEN4GEN Ovarian cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

KREMEN1, USP16, MAS1L, CSMD3, FAT3, GABRA6, CCNE1, PPP2R1A, ERBB2, CDK12, PIK3R1, AKT1, CBLC, PDGFRA, EGFR, PIK3CA, KIT, ARID1A, CTNNB1, NF1 , (...)

View the complete list with 12 more genes
Specificity
7 %
Genes
17 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
High Risk Breast Cancer: Gene Sequencing and Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
29 %
Genes
17 %
Pancreatic Cancer: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

PRSS1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
15 %
Genes
17 %
Pancreatic Cancer: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

PRSS1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL, BRCA2, BRCA1
Specificity
15 %
Genes
17 %
CEN4GEN Comprehensive Solid tumors (somatic genetic testing): Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

ESR1, SMO, ERBB2, AKT1, IDH1, PDGFRA, EGFR, PIK3CA, KIT, MTOR, CTNNB1, MET, CDKN2A, STK11, PTCH1, ATM, MAP2K2, FGFR2, NRAS, KRAS , (...)

View the complete list with 12 more genes
Specificity
7 %
Genes
17 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA mutation.

By Genomic Laboratory Semmelweis University in Hungary.

BRCA2, BRCA1
Specificity
100 %
Genes
17 %
BRCA2.

By Molecular Diagnostic Laboratory Kingston General Hospital in Canada.

BRCA2
Specificity
100 %
Genes
9 %
Hereditary Melanoma Panel.

By Baylor Miraca Genetics Laboratories in United States.

CDKN2A, CDK4, TP53, BRCA2
Specificity
25 %
Genes
9 %
Breast-ovarian cancer, familial 2 (BRCA2).

By Center for Human Genetics, Inc in United States.

BRCA2
Specificity
100 %
Genes
9 %
Bone Marrow Failure.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

RPL36, USB1, RPS7, RPS15, THPO, RPS27A, SRP72, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, NOP10, NHP2 , (...)

View the complete list with 23 more genes
Specificity
5 %
Genes
17 %
Bone Marrow Failure Syndromes Panel by next-generation sequencing (NGS).

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

CXCR4, RAC2, LAMTOR2, GFI1, RBM8A, RPL26, VPS45, G6PC3, RPL15, ELANE, CSF3R, RAB27A, USB1, RPS7, SRP72, ERCC4, FANCD2, FANCI, FANCL, FANCM , (...)

View the complete list with 39 more genes
Specificity
2 %
Genes
9 %
Fanconi Anemia Panel by next-generation sequencing (NGS).

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

ERCC4, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
9 %
Bone Marrow Failure Syndromes Deletion/Duplication Panel.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

CXCR4, RAC2, LAMTOR2, GFI1, RBM8A, RPL26, VPS45, G6PC3, ELANE, CSF3R, RAB27A, USB1, RPS7, SRP72, ERCC4, FANCI, FANCL, FANCM, SLX4, FANCE , (...)

View the complete list with 35 more genes
Specificity
2 %
Genes
9 %
Fanconi Anemia Deletion/Duplication Panel.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

ERCC4, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
9 %
Inherited Bone Marrow Failure Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

SAMD9L, SAMD9, NAF1, POT1, DNAJC21, ACD, CXCR4, GFI1, RBM8A, RPL26, VPS45, G6PC3, RPL15, ELANE, CSF3R, USB1, RPS7, SRP72, ERCC4, XRCC2 , (...)

View the complete list with 41 more genes
Specificity
2 %
Genes
9 %
Breast Cancer BRCA2.

By Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital in New Zealand.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2.

By Institute for Human Genetics University Clinic Freiburg in Germany.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2-Hereditary Cancer of the Breast.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

BRCA2
Specificity
100 %
Genes
9 %
BRCA Portuguese 1-mutation panel specific site analysis.

By Ambry Genetics in United States.

BRCA2
Specificity
100 %
Genes
9 %
Prostate cancer (sequence analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
9 %
Familial pancreatic carcinoma (sequence analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
9 %
Congenital Limb Malformation Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

LMBR1, NOG, FMN1, FBXW4, FBLN1, IHH, WNT3, BMP2, TBX3, HDAC4, GDF5, DOCK6, ARHGAP31, HOXD13, SF3B4, LRP4, WNT7A, TBX15, ROR2, ESCO2 , (...)

View the complete list with 49 more genes
Specificity
2 %
Genes
9 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By MGZ Medical Genetics Center in Germany.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By Bioscientia GmbH Center for Human Genetics in Germany.

BRCA2
Specificity
100 %
Genes
9 %
Prostate cancer.

By Centogene AG - the Rare Disease Company in Germany.

BRCA2
Specificity
100 %
Genes
9 %
Fanconi anemia type D1.

By Centogene AG - the Rare Disease Company in Germany.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2 deletion/duplication testing.

By Michigan Medical Genetics Laboratories University of Michigan in United States.

BRCA2
Specificity
100 %
Genes
9 %
Bone marrow failure syndromes Panel.

By CeGaT GmbH in Germany.

IFNG, LIG4, STXBP2, STX11, SRP72, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, NOP10, NHP2, WRAP53, CTC1, CSF2RA , (...)

View the complete list with 17 more genes
Specificity
6 %
Genes
17 %
Test for BRCA2 Hereditary Breast and Ovarian Cancer.

By All Wales Genetics Laboratory Institute of Medical Genetics in United Kingdom.

BRCA2
Specificity
100 %
Genes
9 %
Hereditary breast/ovarian cancer - analysis the BRCA2 gene mutations in accordance with EMQN recommendations.

By Laboratory of Human Genetics GENOMED Health Care Center in Poland.

BRCA2
Specificity
100 %
Genes
9 %
Fanconi Anemia.

By Asper Biogene Asper Biogene LLC in Estonia.

ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
6 %
Genes
9 %
BRCA2 sequencing.

By Molecular Diagnostics Laboratory Seoul National University Hospital in South Korea.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By Clinical Genomics Maastricht University Medical Centre in Netherlands.

BRCA2
Specificity
100 %
Genes
9 %
Breast-Ovarian cancer, familial 2.

By MedGene in Slovakia.

BRCA2
Specificity
100 %
Genes
9 %
Invitae Melanoma Panel.

By Invitae in United States.

POT1, BAP1, MITF, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2
Specificity
12 %
Genes
9 %
Breast and ovarian cancer, Hereditary: BRCA2 gene sequence analysis and deletions-duplications analysis (MLPA).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2
Specificity
100 %
Genes
9 %
Fanconi anemia.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
9 %
Medical EmExome Array: Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRCA2
Specificity
100 %
Genes
9 %
Fanconi Anemia NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

ERCC4, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
9 %
Intellectual Disability NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

AQP7, TPH2, AFP, XIST, SNIP1, ZBTB24, GLUL, DIP2B, KCNK9, UPB1, CEP57, FTO, ZBTB16, TMCO1, IRX5, AGT, IGF1R, MRAP, HDAC4, IGF1 , (...)

View the complete list with 372 more genes
Specificity
1 %
Genes
17 %
BRCA2.

By Fulgent Genetics Fulgent Genetics in United States.

BRCA2
Specificity
100 %
Genes
9 %
Melanoma Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

BAP1, MITF, CHEK2, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2
Specificity
23 %
Genes
17 %
Fanconi Anemia Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
6 %
Genes
9 %
Anemia Panel.

By Blueprint Genetics in Finland.

RPS29, TMPRSS6, DHFR, TF, REN, DNAJC21, LPIN2, C15orf41, GSS, TPI1, RHAG, EPB42, ANK1, SPTA1, SPTB, RPL15, SLC4A1, RPS7, ERCC4, XRCC2 , (...)

View the complete list with 58 more genes
Specificity
3 %
Genes
17 %
Hereditary breast�¢����ovarian cancer syndrome type 2.

By Bioarray in Spain.

BRCA2
Specificity
100 %
Genes
9 %
Inherited Bone Marrow Failure Panel.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

TERF1, TERF2, DDX41, POT1, TERF2IP, ACD, GFI1, RPL26, G6PC3, RPL15, ELANE, CSF3R, ETV6, RPS7, THPO, SRP72, ERCC4, XRCC2, FANCD2, FANCI , (...)

View the complete list with 38 more genes
Specificity
2 %
Genes
9 %
FANCONI ANEMIA: NGS PANEL.

By Laboratorio de Genetica Clinica SL in Spain.

UBE2T, ERCC4, XRCC2, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
6 %
Genes
9 %
PROSTATE CANCER.

By Laboratorio de Genetica Clinica SL in Spain.

CHEK2, BRCA2
Specificity
100 %
Genes
17 %
Breast and Ovarian Hereditary Cancer, Sequencing BRCA2 Gene.

By Reference Laboratory Genetics in Spain.

BRCA2
Specificity
100 %
Genes
9 %
Glioma (Susceptibility to Somatic) , Panel Massive Sequencing (NGS) 12 Genes.

By Reference Laboratory Genetics in Spain.

ERBB2, IDH1, EGFR, PIK3CA, LGI1, BRAF, PRKN, IDH2, RB1, TP53, PTEN, BRCA2
Specificity
9 %
Genes
9 %
Phosphorus Leukemia including Fanconi Anemia Genes Panel.

By Phosphorus Diagnostics LLC in United States.

ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, TERT, TERC, DKC1, FANCB, NF1, RAD51C, CEBPA, GATA2, BRIP1 , (...)

View the complete list with 15 more genes
Specificity
6 %
Genes
17 %
Phosphorus Melanoma Panel.

By Phosphorus Diagnostics LLC in United States.

POT1, BAP1, MITF, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2
Specificity
12 %
Genes
9 %
CEN4GEN Gastric cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WNK2, ADGRB3, SSTR1, TRRAP, LRP1B, LPAR2, GPR78, ATP4A, CCNE1, TRIO, DCC, MYC, ERBB2, PRKDC, FBXW7, PIK3CA, SPEG, NOTCH1, CTNNB1, S1PR2 , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
9 %
Melanoma: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WRN, BAP1, KIT, CDKN2A, CDK4, NRAS, BRAF, RB1, TP53, PTEN, BRCA2
Specificity
10 %
Genes
9 %
Hereditary Leukemia/Lymphoma Panel.

By Baylor Miraca Genetics Laboratories in United States.

PRF1, CEBPA, SBDS, PAX5, GATA2, BRIP1, PALB2, ATM, CBL, PTPN11, TP53, RUNX1, BRCA2
Specificity
8 %
Genes
9 %
Fanconi Anemia Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
9 %
BRCA2 Targeted Analysis (BRCAssure).

By Molecular Diagnostic Laboratory LabCorp in United States.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2 Gene Analysis.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2 Single Mutation Analysis.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA2
Specificity
100 %
Genes
9 %
PANEXIA.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

PALB2, BRCA2
Specificity
50 %
Genes
9 %
Fanconi Anemia Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

UBE2T, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
6 %
Genes
9 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By Molecular Genetics Rabin Medical Center in Israel.

BRCA2
Specificity
100 %
Genes
9 %
MelanomaNext.

By Ambry Genetics in United States.

BAP1, MITF, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2
Specificity
13 %
Genes
9 %
BRCA2. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2. MLPA testing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

BRCA2
Specificity
100 %
Genes
9 %
Familial breast/ovarian cancer (deletion/duplication analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
9 %
Fanconi anemia (NGS panel for 15 genes).

By CGC Genetics in Portugal.

FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
9 %
Familial breast/ovarian cancer (sequence analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
9 %
Familial pancreatic carcinoma (sequence analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
9 %
Prostate cancer (sequence analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
9 %
Fanconi Anemia via BRCA2/FANCD1 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

BRCA2
Specificity
100 %
Genes
9 %
Melanoma Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POT1, BAP1, MITF, CHEK2, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2
Specificity
20 %
Genes
17 %
Pancreatic Cancer.

By MGZ Medical Genetics Center in Germany.

PMS1, CHEK2, CDKN2A, STK11, PALB2, PTEN, MLH1, MSH6, PMS2, MSH2, BRCA2
Specificity
19 %
Genes
17 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By Bioscientia GmbH Center for Human Genetics in Germany.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2.

By GeneTech ATS GeneTech Private Limited in India.

BRCA2
Specificity
100 %
Genes
9 %
Breast cancer.

By Centogene AG - the Rare Disease Company in Germany.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2 Gene Sequencing.

By Michigan Medical Genetics Laboratories University of Michigan in United States.

BRCA2
Specificity
100 %
Genes
9 %
Hereditary Breast and Ovarian Cancer 2.

By Medical Genetics Laboratory Diagenom GmbH in Germany.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2 mutations.

By Medical Genetics Institute Shaare Zedek Medical Center in Israel.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2.

By Innovagenomics Innovagenomics S.L in Spain.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By GGA - Galil Genetic Analysis in Israel.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2.

By ProntoLab - MLPA Lab Pronto Diagnostics Ltd. in Israel.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2 Deletion Duplication (MLPA).

By Advanced Molecular Diagnostics Mount Sinai Hospital in Canada.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2 Gene Sequencing.

By Advanced Molecular Diagnostics Mount Sinai Hospital in Canada.

BRCA2
Specificity
100 %
Genes
9 %
Breast-Ovarian cancer, familial 2.

By Praxis fuer Humangenetik Wien in Austria.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By Department of Clinical Genetics St. Elisabeth Cancer Institute in Slovakia.

BRCA2
Specificity
100 %
Genes
9 %
Invitae Bone Marrow Failure Syndromes Panel.

By Invitae in United States.

RPL26, ELANE, RPS7, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, NOP10, NHP2, CTC1, TERT, TERC, DKC1 , (...)

View the complete list with 19 more genes
Specificity
3 %
Genes
9 %
Invitae Fanconi Anemia Panel.

By Invitae in United States.

ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
6 %
Genes
9 %
Breast and ovarian cancer, Hereditary: BRCA2 gene deletions-duplications analysis (MLPA).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2
Specificity
100 %
Genes
9 %
Breast and ovarian cancer, Hereditary: BRCA2 gene screening (founder mutations in Spanish families).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2
Specificity
100 %
Genes
9 %
Breast and ovarian cancer, Hereditary: BRCA2 gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2
Specificity
100 %
Genes
9 %
Fanconi Anemia Panel.

By Blueprint Genetics in Finland.

CXCR4, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, ATR, FANCB, RAD51C, BRIP1, PALB2, NBN, ATM, BLM , (...)

View the complete list with 2 more genes
Specificity
10 %
Genes
17 %
Hereditary Lung Cancer Panel.

By Blueprint Genetics in Finland.

EGFR, CDKN2A, TP53, BRCA2
Specificity
25 %
Genes
9 %
Limb Malformations Panel.

By Blueprint Genetics in Finland.

DLL4, BHLHA9, EOGT, TBX3, GDF5, RBPJ, DOCK6, ARHGAP31, SF3B4, WNT7A, ESCO2, RBM8A, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
9 %
Hereditary Pancreatic Cancer (BRCA2, PALB2).

By GeneKor MSA in Greece.

PALB2, BRCA2
Specificity
50 %
Genes
9 %
BRCA2 Mutation & Del/Dup Analysis.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

BRCA2
Specificity
100 %
Genes
9 %
BRCA2.

By Caris Life Sciences in United States.

BRCA2
Specificity
100 %
Genes
9 %
Breast and Ovarian Hereditary Cancer, Deletions-Duplications (MLPA) BRCA2 Gene.

By Reference Laboratory Genetics in Spain.

BRCA2
Specificity
100 %
Genes
9 %
Fanconi Anemia , Panel Massive Sequencing (NGS) 15 Genes.

By Reference Laboratory Genetics in Spain.

XRCC2, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
9 %
Bone Marrow Failure Related Disorders , Panel Massive Sequencing (NGS) 59 Genes.

By Reference Laboratory Genetics in Spain.

CXCR4, RAC2, LAMTOR2, GFI1, RBM8A, RPL26, G6PC3, ELANE, CSF3R, JAK2, RAB27A, USB1, RPS7, SRP72, ERCC4, FANCD2, FANCI, FANCL, SLX4, FANCE , (...)

View the complete list with 38 more genes
Specificity
2 %
Genes
9 %
Cutaneous Malignant Melanoma , Panel Massive Sequencing (NGS) 10 Genes.

By Reference Laboratory Genetics in Spain.

BAP1, TERT, MITF, CDKN2A, CDK4, MC1R, RB1, TP53, PTEN, BRCA2
Specificity
10 %
Genes
9 %
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, MRE11, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
9 %
GeneAware Complete Panel Version 2 (Female).

By Baylor Miraca Genetics Laboratories in United States.

TMEM216, DPYD, TGM1, RAPSN, PKHD1, PLA2G6, PHGDH, LAMC2, EIF2B5, CLN5, CAPN3, BTK, ABCC8, WAS, TTPA, SUMF1, SLC17A5, SLC12A6, SGCG, RTEL1 , (...)

View the complete list with 139 more genes
Specificity
1 %
Genes
9 %
GeneAware Complete Panel Version 2 (Male).

By Baylor Miraca Genetics Laboratories in United States.

TMEM216, DPYD, TGM1, RAPSN, PKHD1, PLA2G6, PHGDH, LAMC2, EIF2B5, CLN5, CAPN3, ABCC8, WAS, TTPA, SUMF1, SLC17A5, SLC12A6, SGCG, RTEL1, POMGNT1 , (...)

View the complete list with 129 more genes
Specificity
1 %
Genes
9 %
Vistaseq Hereditary Cancer Panel Without BRCA.

By Molecular Diagnostic Laboratory LabCorp in United States.

ABRAXAS1, RAD51D, BARD1, RAD51C, PRKAR1A, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 5 more genes
Specificity
8 %
Genes
17 %
VistaSeq Brain/CNS/PNS Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

SMARCB1, NF1, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, MEN1, RB1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
9 %
Chromosome Breakage Disorders Panel by next-generation sequencing (NGS).

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

LIG4, NHEJ1, NBN, ATM, BLM
Specificity
20 %
Genes
9 %
NBN Sequencing.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

NBN
Specificity
100 %
Genes
9 %
Chromosome Breakage Disorders Deletion/Duplication Panel.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

LIG4, NHEJ1, NBN, ATM, BLM
Specificity
20 %
Genes
9 %
NBN Deletion/duplication analysis.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

NBN
Specificity
100 %
Genes
9 %
Microcephaly Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

SLC1A4, PPP1R15B, USP18, TUBGCP6, ASXL3, TUBGCP4, PYCR2, CRIPT, PLK4, ORC4, ORC6, CDT1, CDC6, ORC1, NIN, TRAPPC9, CEP63, KNL1, CEP135, ZNF335 , (...)

View the complete list with 59 more genes
Specificity
2 %
Genes
9 %
Primary Antibody Deficiency Panel, Sequencing (35 Genes) and Deletion/Duplication (26 Genes).

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

IGHM, CD79B, IGLL1, CD79A, BLNK, LRRC8A, VAV1, PLCG2, PRKCD, MS4A1, TNFRSF13C, ICOS, CD81, CR2, CD19, PIK3R1, NFKB2, NFKBIA, LRBA, PIK3CD , (...)

View the complete list with 15 more genes
Specificity
3 %
Genes
9 %
Hereditary Cancer Panel - Neuro17.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

NF1, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, TSC1, TSC2, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
9 %
BrainTumorNext.

By Ambry Genetics in United States.

DICER1, POT1, AIP, CDKN1B, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, CDKN2A, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, TSC1, TSC2, MEN1, TP53 , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
9 %
NBS. Detection of the mutation c.657del5 by sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

NBN
Specificity
100 %
Genes
9 %
NBS. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

NBN
Specificity
100 %
Genes
9 %
NBN. Detection of the mutation c.657_661del5 by sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

NBN
Specificity
100 %
Genes
9 %
Hereditary Brain Tumor Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

SMARCB1, SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
9 %
Nijmegen Breakage Syndrome (sequence analysis of NBN gene).

By CGC Genetics in Portugal.

NBN
Specificity
100 %
Genes
9 %
Hyper IgM Syndrome Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

NFKBIA, PIK3CD, CD40LG, CD40, AICDA, SH2D1A, BTK, NBN, MRE11, ATM, UNG
Specificity
10 %
Genes
9 %
Nijmegen Breakage Syndrome via NBN Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

NBN
Specificity
100 %
Genes
9 %
Chromosomal Instability Syndromes Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

WRN, ERCC8, ERCC6, NBN, MRE11, ATM, BLM, RECQL4
Specificity
13 %
Genes
9 %
Mental retardation - different panels.

By Institute of Human Genetics Cologne University in Germany.

EEF1B2, UBR7, PARP1, CAPN10, SLC31A1, TRMT1, PGAP2, GMPPA, TANGO2, IMPA1, RALGDS, ZBTB40, KCNK9, SETD1A, HERC2, TM4SF20, AHDC1, CCDC88A, ACBD6, KDM5A , (...)

View the complete list with 847 more genes
Specificity
1 %
Genes
9 %
Colorectal Cancer.

By MGZ Medical Genetics Center in Germany.

BUB1B, PMS1, SMAD4, BMPR1A, CHEK2, MET, STK11, NBN, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC
Specificity
13 %
Genes
17 %
Aplastic anemia.

By Centogene AG - the Rare Disease Company in Germany.

NBN
Specificity
100 %
Genes
9 %
AllNeuro panel.

By Centogene AG - the Rare Disease Company in Germany.

FCGR2B, TNF, ALOX5AP, PRKCH, TLR5, TIRAP, NOS2, XBP1, KCNK18, AANAT, SNIP1, EIF4E, ZBTB18, ADAM10, YAP1, ICAM1, SNX3, CISH, TAS2R38, FRG1 , (...)

View the complete list with 1185 more genes
Specificity
1 %
Genes
9 %
Bone marrow failure syndromes with Leukemia Panel.

By CeGaT GmbH in Germany.

CASP10, GATA1, CEBPA, NBN, RUNX1
Specificity
20 %
Genes
9 %
Syndromes with immunodeficiency Panel.

By CeGaT GmbH in Germany.

SP110, RPSA, FCGR3A, ZBTB24, MCM4, SPINK5, RNF168, DNMT3B, TYK2, SMARCAL1, PDGFRA, NOD2, NHP2, CFH, FGF10, ADAR, DOCK8, TERT, TERC, DKC1 , (...)

View the complete list with 18 more genes
Specificity
3 %
Genes
9 %
Nijmegen Breakage Syndrome.

By Asper Biogene Asper Biogene LLC in Estonia.

NBN
Specificity
100 %
Genes
9 %
Family Prep Screen.

By Counsyl in United States.

BCHE, HGD, F11, MEFV, VPS13B, CYP21A2, TMEM216, DPYD, PKHD1, LAMC2, CLN5, ABCC8, TTPA, SLC17A5, SLC12A6, POMGNT1, PEX1, MCOLN1, MLC1, LAMA3 , (...)

View the complete list with 90 more genes
Specificity
1 %
Genes
9 %
qCarrier Plus.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

MPP3, FTCD, ADK, CTH, HAL, HGD, WNT10A, SLC6A19, TPO, SLC5A5, DUOX2, DUOXA2, PAX8, HJV, HOGA1, TFR2, COL7A1, SLC39A4, ARL13B, FANCA , (...)

View the complete list with 280 more genes
Specificity
1 %
Genes
9 %
Invitae Pediatric Hematologic Malignancies Panel.

By Invitae in United States.

TERT, TERC, NF1, CEBPA, GATA2, NBN, ATM, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
7 %
Genes
9 %
Invitae Myelodysplastic Syndrome/Leukemia Panel.

By Invitae in United States.

TERT, TERC, NF1, CEBPA, GATA2, NBN, ATM, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
7 %
Genes
9 %
Invitae Primary Immunodeficiency Panel.

By Invitae in United States.

IRF7, RORC, DCLRE1B, DOCK2, MAP3K14, NFAT5, IL17RC, TAPBP, TAP2, TNFRSF4, RHOH, FPR1, SP110, TNFSF12, IKBKB, LCK, CTPS1, ZBTB24, ADAM17, BCL10 , (...)

View the complete list with 187 more genes
Specificity
1 %
Genes
9 %
Ataxia Telangiectasia variant 1[Nijmegen breakage syndrome]: NBS1 gene deletion analysis (c.657_661del5).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

NBN
Specificity
100 %
Genes
9 %
Ataxia Telangiectasia variant 1[Nijmegen breakage syndrome]: NBS1 gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

NBN
Specificity
100 %
Genes
9 %
Proportionate Short Stature/Small for Gestational Age: Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SHOX2, IGF1R, IGF1, TBCE, WRN, CUL7, ROR2, SRCAP, SMARCAL1, STAT5B, INSR, TRIM37, EP300, THRB, LHX3, ERCC6, KDM6A, GLI2, SOX3, RPS6KA3 , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
9 %
Brain, CNS, and PNS Cancer: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
7 %
Genes
9 %
Pan-Ethnic Carrier Screen: Gene Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

HMOX1, LIPH, NLRP7, EDAR, WISP3, WRN, GP9, TTC37, GP1BB, F9, VWF, F11, MEFV, CTSC, SLC19A2, VPS13B, CYP21A2, GHRHR, TMEM216, DPYD , (...)

View the complete list with 127 more genes
Specificity
1 %
Genes
9 %
Brain, CNS, and PNS Cancer: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, MSH2, APC, VHL
Specificity
7 %
Genes
9 %
Inheritest NGS, Comprehensive.

By Integrated Genetics Westborough Integrated Genetics in United States.

XPC, XPA, ERCC5, GSS, MEFV, NEU1, PEX12, PEX10, PEX26, FUCA1, PEX6, VPS13B, TMEM216, DPYD, PKHD1, PHGDH, LAMC2, CLN5, ABCC8, TTPA , (...)

View the complete list with 120 more genes
Specificity
1 %
Genes
9 %
Chromosomal Instability Syndromes NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

WRN, ERCC8, ERCC6, NBN, MRE11, ATM, BLM
Specificity
15 %
Genes
9 %
NBN.

By Fulgent Genetics Fulgent Genetics in United States.

NBN
Specificity
100 %
Genes
9 %
Sarcoma Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

DICER1, WRN, PDGFRA, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHA, SDHB, FH, SDHC, RB1, TP53, RECQL4 , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
9 %
Primary Immunodeficiency Panel.

By Blueprint Genetics in Finland.

BCL11B, OTULIN, IRF2BP2, RASGRP1, CARMIL2, ZNF341, TFRC, POLE2, HYOU1, JAK1, ARPC1B, BACH2, LAT, MRTFA, MSN, GINS1, CD59, ADAM17, BCL10, IRF8 , (...)

View the complete list with 255 more genes
Specificity
1 %
Genes
9 %
Nijmegen Breakage Syndrome.

By Bioarray in Spain.

NBN
Specificity
100 %
Genes
9 %
Nijmegen Breakage Syndrome , Sequencing NBN Gene.

By Reference Laboratory Genetics in Spain.

NBN
Specificity
100 %
Genes
9 %
Chromosome Breakage Related Disorders , Panel Massive Sequencing (NGS) 8 Genes.

By Reference Laboratory Genetics in Spain.

WRN, ERCC8, ERCC6, NBN, MRE11, ATM, BLM, RECQL4
Specificity
13 %
Genes
9 %
Hereditary Sarcoma (Susceptibility to) , Panel Massive Sequencing (NGS) 25 Genes.

By Reference Laboratory Genetics in Spain.

DICER1, WRN, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHB, FH, SDHC, SDHAF2, RB1, TP53, RECQL4, MLH1 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
9 %
Pan-Ethnic Carrier Screen: Full Gene Sequencing and SMA Analysis.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

HMOX1, LIPH, NLRP7, EDAR, WISP3, WRN, GP9, TTC37, GP1BB, F11, MEFV, CTSC, SLC19A2, VPS13B, CYP21A2, GHRHR, TMEM216, DPYD, PKHD1, LAMC2 , (...)

View the complete list with 116 more genes
Specificity
1 %
Genes
9 %
Brain, CNS, and PNS Cancer: Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
7 %
Genes
9 %
Nijmegen Breakage Syndrome: gene sequencing.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

NBN
Specificity
100 %
Genes
9 %
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, MRE11, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
9 %
Microcephaly Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

TUBGCP6, ASXL3, TUBGCP4, PYCR2, CRIPT, PLK4, ORC4, ORC6, CDT1, CDC6, ORC1, TRAPPC9, CEP63, KNL1, CEP135, ZNF335, CDK6, PHC1, CENPE, MFSD2A , (...)

View the complete list with 50 more genes
Specificity
2 %
Genes
9 %
NBN.

By Institute for Human Genetics University Clinic Freiburg in Germany.

NBN
Specificity
100 %
Genes
9 %
NBN. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

NBN
Specificity
100 %
Genes
9 %
NBN. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

NBN
Specificity
100 %
Genes
9 %
NBN. Detection of the mutation c.657del5 by sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

NBN
Specificity
100 %
Genes
9 %
Njimegen Breakage Syndrome.

By Institute of Human Genetics Cologne University in Germany.

NBN
Specificity
100 %
Genes
9 %
NBN.

By MGZ Medical Genetics Center in Germany.

NBN
Specificity
100 %
Genes
9 %
Breast ovarian cancer panel.

By Centogene AG - the Rare Disease Company in Germany.

RAD51, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MSH6
Specificity
15 %
Genes
17 %
Familial Tumor Syndromes Panel.

By CeGaT GmbH in Germany.

RASAL1, CYLD, DICER1, WRN, AKT1, PIK3CA, BAP1, SMARCB1, SMARCA4, SMARCE1, ATR, SPRED1, LZTR1, NF1, CDC73, MET, SDHD, CDKN2A, NF2, NBN , (...)

View the complete list with 12 more genes
Specificity
4 %
Genes
9 %
Colon Cancer Panel.

By CeGaT GmbH in Germany.

AXIN1, RINT1, POLE, POLD1, SMAD4, BMPR1A, CHEK2, FLCN, STK11, NBN, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
11 %
Genes
17 %
Brain malformations.

By Asper Biogene Asper Biogene LLC in Estonia.

CLP1, TUBGCP6, SEPSECS, AMPD2, CEP63, KNL1, CEP135, LAMB1, SNAP29, ERMARD, KIF2A, KIF5C, TUBB, TUBG1, RTTN, TBC1D20, CCND2, ZNF423, OCLN, TCTN3 , (...)

View the complete list with 125 more genes
Specificity
1 %
Genes
9 %
Invitae Sarcoma Panel.

By Invitae in United States.

DICER1, WRN, PDGFRA, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHA, SDHB, FH, SDHC, RB1, TP53, RECQL4 , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
9 %
Invitae Pediatric Solid Tumors Panel.

By Invitae in United States.

DIS3L2, DICER1, WRN, AXIN2, BAP1, SMARCB1, SMARCA4, SMARCE1, NF1, CDC73, PRKAR1A, SMAD4, BMPR1A, MAX, GPC3, SDHD, CDKN1C, STK11, SUFU, NF2 , (...)

View the complete list with 28 more genes
Specificity
3 %
Genes
9 %
Invitae Nijmegen Breakage Syndrome Test.

By Invitae in United States.

NBN
Specificity
100 %
Genes
9 %
Invitae Syndromic Combined Immunodeficiency (CID) Panel.

By Invitae in United States.

DCLRE1B, SP110, ZBTB24, SPINK5, DNMT3B, PGM3, ACD, TTC7A, SMARCAL1, EPG5, WIPF1, NFKBIA, FOXN1, ORAI1, STAT5B, POLE, STIM1, NOP10, NHP2, CTC1 , (...)

View the complete list with 17 more genes
Specificity
3 %
Genes
9 %
Nijmegen Breakage Syndrome (NBN).

By Integrated Genetics Westborough Integrated Genetics in United States.

NBN
Specificity
100 %
Genes
9 %
Hematologic Malignancy Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

TERT, TERC, NF1, CEBPA, GATA2, NBN, ATM, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
7 %
Genes
9 %
Hereditary Pediatric Cancer Panel.

By Blueprint Genetics in Finland.

REST, DIS3L2, BUB1B, DICER1, WRN, AXIN2, BAP1, SMARCB1, SMARCA4, EZH2, RRAS, RASA2, NSUN2, LZTR1, NF1, CDC73, PRKAR1A, PRF1, CEBPA, PAX5 , (...)

View the complete list with 51 more genes
Specificity
2 %
Genes
9 %
Nijmegen breakage syndrome.

By Bioarray in Spain.

NBN
Specificity
100 %
Genes
9 %
Ataxia Telangiectasia (Nijmegen Breakage Syndrome) , Deletion NBN Gene.

By Reference Laboratory Genetics in Spain.

NBN
Specificity
100 %
Genes
9 %
Idiopathic Aplastic Anemia , Panel Massive Sequencing (NGS) 6 Genes.

By Reference Laboratory Genetics in Spain.

IFNG, TERT, TERC, PRF1, SBDS, NBN
Specificity
17 %
Genes
9 %
Phosphorus Leukemia Panel.

By Phosphorus Diagnostics LLC in United States.

TERT, TERC, DKC1, NF1, CEBPA, GATA2, NBN, ATM, TINF2, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
6 %
Genes
9 %
Phosphorus Pediatric Cancers Panel.

By Phosphorus Diagnostics LLC in United States.

DIS3L2, DICER1, WRN, AXIN2, BAP1, SMARCB1, TERT, TERC, EZH2, NF1, CDC73, PRKAR1A, CEBPA, GATA2, SMAD4, BMPR1A, MAX, GPC3, SDHD, CDKN1C , (...)

View the complete list with 33 more genes
Specificity
2 %
Genes
9 %
Brain, CNS, and PNS Cancer: Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, MSH2, APC, VHL
Specificity
7 %
Genes
9 %
Tier 1: Hereditary Lymphoma and Immunodeficiency Panel.

By Genetic Services Laboratory University of Chicago in United States.

NPAT, POT1, TERF2IP, KLHDC8B, ACD, CHEK2, TP53, MLH1, MSH6, PMS2, MSH2
Specificity
10 %
Genes
9 %
CHEK2.

By Institute for Human Genetics University Clinic Freiburg in Germany.

CHEK2
Specificity
100 %
Genes
9 %
Colorectal Cancer Panel.

By GeneDx in United States.

AXIN2, POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
6 %
Genes
9 %
Hereditary Cancer Panel - Colorectal20.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

GALNT12, AXIN2, POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
5 %
Genes
9 %
Li-Fraumeni syndrome (deletions/duplication on CHEK2 gene).

By CGC Genetics in Portugal.

CHEK2
Specificity
100 %
Genes
9 %
Breast cancer, susceptibility to (deletion/duplication analysis of CHEK2 gene).

By CGC Genetics in Portugal.

CHEK2
Specificity
100 %
Genes
9 %
Colorectal Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POLE, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
6 %
Genes
9 %
Li-Fraumeni Syndrome, CHEK2-Related.

By MGZ Medical Genetics Center in Germany.

CHEK2
Specificity
100 %
Genes
9 %
Polyposis Coli.

By MGZ Medical Genetics Center in Germany.

SMAD4, BMPR1A, CHEK2, STK11, PTEN, MUTYH, APC
Specificity
15 %
Genes
9 %
Thyroid Cancer.

By MGZ Medical Genetics Center in Germany.

DICER1, CHEK2, FLCN, SDHD, STK11, ATM, MEN1, SDHB, SDHC, RET, PTEN, MUTYH, APC
Specificity
8 %
Genes
9 %
CentoColon extended panel.

By Centogene AG - the Rare Disease Company in Germany.

NTHL1, POLE, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
6 %
Genes
9 %
Li-Fraumeni syndrome type 2.

By Centogene AG - the Rare Disease Company in Germany.

CHEK2
Specificity
100 %
Genes
9 %
qCancer Colorrectal.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
6 %
Genes
9 %
CHEK2.

By Fulgent Genetics Fulgent Genetics in United States.

CHEK2
Specificity
100 %
Genes
9 %
Thyroid Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
9 %
Colorectal Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

MLH3, GALNT12, AXIN2, POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
6 %
Genes
9 %
CHEK2 Sequencing and Deletion/Duplication.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

CHEK2
Specificity
100 %
Genes
9 %
Breast and Ovarian Hereditary Cancer, Mutation (1100 delC) CHEK2 Gene.

By Reference Laboratory Genetics in Spain.

CHEK2
Specificity
100 %
Genes
9 %
Breast and Ovarian Hereditary Cancer, Deletions-Duplications (MLPA) CHEK2 Gene.

By Reference Laboratory Genetics in Spain.

CHEK2
Specificity
100 %
Genes
9 %
Phosphorus Colorectal Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

AXIN2, POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
6 %
Genes
9 %
High Risk Colorectal Cancer: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, APC
Specificity
7 %
Genes
9 %
CHEK2 (Checkpoint Kinase 2) full gene sequencing analysis.

By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center in United States.

CHEK2
Specificity
100 %
Genes
9 %
Hereditary Thyroid Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DICER1, SRGAP1, WRN, AKT1, PIK3CA, PRKAR1A, CHEK2, SDHD, SDHB, RET, TP53, PTEN, APC
Specificity
8 %
Genes
9 %
Comprehensive Hereditary Colorectal Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

GALNT12, BUB1B, AXIN2, POLE, GREM1, POLD1, ENG, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
9 %
CHEK2 gene sequence and deletion/duplication.

By Ambry Genetics in United States.

CHEK2
Specificity
100 %
Genes
9 %
ColoNext.

By Ambry Genetics in United States.

POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
6 %
Genes
9 %
TumorNext-Lynch+ColoNext.

By Ambry Genetics in United States.

POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, NRAS, KRAS, BRAF, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
5 %
Genes
9 %
Li-Fraumeni syndrome type 2 (sequence analysis of CHEK2 gene).

By CGC Genetics in Portugal.

CHEK2
Specificity
100 %
Genes
9 %
Hereditary colon cancer (panel NGS of 21 genes).

By CGC Genetics in Portugal.

MSH3, MLH3, GALNT12, AXIN2, POLE, POLD1, TGFBR2, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
9 %
Hereditary colon cancer (panel NGS of 21 genes).

By CGC Genetics in Portugal.

MSH3, MLH3, GALNT12, AXIN2, POLE, POLD1, TGFBR2, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
9 %
Breast cancer, susceptibility to (deletion/duplication analysis of CHEK2 gene).

By CGC Genetics in Portugal.

CHEK2
Specificity
100 %
Genes
9 %
Renal Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DIS3L2, DICER1, BAP1, SMARCB1, MITF, CDC73, CHEK2, MET, FLCN, SDHD, TSC1, TSC2, SDHA, SDHB, FH, SDHC, WT1, TP53, PTEN, MLH1 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
9 %
Hereditary Breast Cancer via CHEK2 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

CHEK2
Specificity
100 %
Genes
9 %
CHEK2-Related Susceptibility to Breast Cancer.

By MGZ Medical Genetics Center in Germany.

CHEK2
Specificity
100 %
Genes
9 %
Renal Cancer.

By MGZ Medical Genetics Center in Germany.

BAP1, SMARCB1, CHEK2, GPC3, MET, FLCN, SDHD, TSC1, TSC2, SDHB, FH, SDHC, WT1, TP53, PTEN, VHL
Specificity
7 %
Genes
9 %
Gastric Cancer.

By MGZ Medical Genetics Center in Germany.

PMS1, BMPR1A, CHEK2, STK11, CDH1, TP53, MLH1, MSH6, PMS2, MSH2
Specificity
10 %
Genes
9 %
Li - Fraumeni Syndrome, CHEK2-Related.

By GGA - Galil Genetic Analysis in Israel.

CHEK2
Specificity
100 %
Genes
9 %
Invitae Thyroid Cancer Panel.

By Invitae in United States.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
9 %
Invitae Colorectal Cancer Panel.

By Invitae in United States.

AXIN2, POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
6 %
Genes
9 %
High Risk Colorectal Cancer: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC
Specificity
7 %
Genes
9 %
High Risk Colorectal Cancer: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, APC
Specificity
7 %
Genes
9 %
Colon Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

EXO1, GALNT12, BUB1B, AXIN2, PMS1, SMAD4, BMPR1A, CHEK2, FLCN, CDKN2A, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
9 %
Colorectal Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

AXIN2, POLE, POLD1, SMAD4, BMPR1A, CHEK2, STK11, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
7 %
Genes
9 %
COLOTRUE™.

By Pathway Genomics in United States.

MDM2, SMAD4, BMPR1A, CHEK2, STK11, CDH1, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
7 %
Genes
9 %
LI-FRAUMENI SYNDROME TYPE 2.

By Laboratorio de Genetica Clinica SL in Spain.

CHEK2
Specificity
100 %
Genes
9 %
Breast and Ovarian Hereditary Cancer, Sequencing CHEK2 Gene.

By Reference Laboratory Genetics in Spain.

CHEK2
Specificity
100 %
Genes
9 %
Li Fraumeni Syndrome Type 2 , Sequencing CHEK2 Gene.

By Reference Laboratory Genetics in Spain.

CHEK2
Specificity
100 %
Genes
9 %
Hereditary Thyroid Cancer , Panel Massive Sequencing (NGS) 7 Genes.

By Reference Laboratory Genetics in Spain.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
9 %
Phosphorus Thyroid Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
9 %
High Risk Colorectal Cancer: Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SMAD4, BMPR1A, CHEK2, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC
Specificity
7 %
Genes
9 %
MSMB.

By Fulgent Genetics Fulgent Genetics in United States.

MSMB
Specificity
100 %
Genes
9 %
EPHB2.

By Fulgent Genetics Fulgent Genetics in United States.

EPHB2
Specificity
100 %
Genes
9 %
MSR1.

By Fulgent Genetics Fulgent Genetics in United States.

MSR1
Specificity
100 %
Genes
9 %
Prostate cancer 1 (sequence analysis of RNASEL gene).

By CGC Genetics in Portugal.

RNASEL
Specificity
100 %
Genes
9 %
Comprehensive mitochondrial disorders panel.

By Centogene AG - the Rare Disease Company in Germany.

HSPA9, TIMM44, NDUFB9, MIP, BCL2, CRBN, GSR, HADH, SCO1, COX10, LARS2, PDX1, BRIP1, SDHD, SDHA, PDHX, TMLHE, CPOX, OGG1, PPOX , (...)

View the complete list with 160 more genes
Specificity
1 %
Genes
9 %
Prostate cancer.

By Centogene AG - the Rare Disease Company in Germany.

RNASEL
Specificity
100 %
Genes
9 %
RNASEL.

By Fulgent Genetics Fulgent Genetics in United States.

RNASEL
Specificity
100 %
Genes
9 %
Prostate cancer, familial, association with.

By Centogene AG - the Rare Disease Company in Germany.

HOXB13
Specificity
100 %
Genes
9 %
HOXB13.

By Fulgent Genetics Fulgent Genetics in United States.

HOXB13
Specificity
100 %
Genes
9 %
HOXB13 Genotyping.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

HOXB13
Specificity
100 %
Genes
9 %

Alternate names

Prostate Cancer, Hereditary, 1; Hpc1 Is also known as prca1;.



If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like TOOTH AGENESIS, SELECTIVE, 1; STHAG1 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA SHORT QT SYNDROME 3; SQT3 MYD88 DEFICIENCY; MYD88D DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2 VARIANT ABETA2M AMYLOIDOSIS EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more